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ABSTRACT 
RNA:DNA Heteroduplex Resolution in B-Lymphocyte Immunoglobulin Diversification  
and Genomic Maintenance 
David Kazadi 
 Immunoglobulin (Ig) gene diversification plays an essential role in adaptive immunity. 
Faced with a continuous yet varied stream of self, non-self, and possibly harmful molecules, 
many organisms have mechanisms in their arsenal that have evolved to match the diversity of the 
antigens they encounter. In humans and mice, developing B and T lymphocytes go through a first 
round of genomic alteration — V(D)J recombination — in the bone marrow and the thymus, 
respectively. B cells can subsequently undergo two additional Ig gene diversification processes in 
secondary lymphoid tissues. Through somatic hypermutation (SHM), Ig variable regions of 
stimulated germinal center (GC)-forming B cells are mutated and further diversified, enabling 
affinity maturation. During class-switch recombination (CSR), on the other hand, B cells in the 
GC or prior to entering the GC recombine Ig constant regions, swapping the IgM-encoding locus 
for another isotype constant regions gene (e.g., IgG1, IgG3, IgE, IgA) to allow for different 
effector functions. Both B cell-specific genomic alterations are initiated when the single-stranded 
DNA (ssDNA) mutator enzyme activation-induced cytidine deaminase (AID) catalyzes the 
removal of the amino group off deoxycytidine residues, resulting in deoxyuridines and dU:dG 
mismatches. Low-fidelity cellular responses to the presence of dU, including the mismatch repair 
(MMR) and the base-excision repair (BER) pathways, are then thought to introduce mutations in 
SHM and CSR, as well as cause double-strand breaks (DSBs) repaired through canonical and 
alternative non-homologous end-joining in CSR. 
 Though necessary for proper physiological function, these lymphocyte genome 
diversification processes are rife with danger for B cells and there is strong selective pressure to 
carefully orchestrate and target them so as not to threaten the genomic integrity of the cells 
through breaks or other mutations at non-Ig loci. Yet, these events can still occur, as 
demonstrated by the implication of AID with translocations found in some cancers (e.g., c-
MYC:IGH in Burkitt’s lymphoma). Therefore, the mechanisms underlying AID mutagenic 
activity targeting to physiological deamination substrates have been the focus of several studies.  
 Protein kinase A (PKA)-dependent phosphorylation of AID at its serine 38 residue has 
been shown to enable its interaction with replication protein A (RPA) before binding to ssDNA. 
Others have reported that SPT5 helps target AID to sites of RNA polymerase II (Pol II) stalling, 
such as the Ig switch sequences. Another cofactor, the RNA exosome complex, helps target the 
ssDNA mutator AID to both strands of DNA in vivo. The RNA exosome had hitherto been 
described in the context of RNA processing and degradation as 3’ → 5’ exoribonuclease. Sterile 
transcript-generating transcription at Ig loci was known to be required for proper AID catalytic 
activity; the newly described link between the RNA exosome and AID activity raised the 
prospect that RNA processing, and not mere transcription, might be playing a role in shaping the 
diversification of the immune repertoire in B lymphocytes. 
 During CSR, transient three-strand structures called R loops are generated. R loops are 
formed as the nascent transcript invades the DNA duplex, hybridizing to the template strand, and 
displacing the non-template one. The G-rich nature of the non-template strand is posited to help 
stabilize the R loop, which allows the ssDNA mutator AID to use the exposed, non-template 
strand as a substrate. AID must then access the template strand. Here, we investigate the role that 
the RNA exosome and a potential cofactor, the putative RNA/DNA helicase senataxin (SETX), 
play in the sequence of biological events that result in CSR while protecting the cell from R-loop 
accumulation-associated genomic instability.  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Chapter I: Introduction 
"1
I.1. An Evolutionary Perspective 
 Conceptual evidence for what we today refer to as the immune system can be found as far 
back as in some of the earliest forms of terrestrial life. Deoxyribonucleic acid (DNA) restriction 
and surface exclusion in bacteria and archaea, for instance, evolved alongside horizontal gene 
transfer as a way to curtail the oftentimes maladaptive consequences of the latter. In eukaryotes, 
ribonucleic acid (RNA)-interference provides an early and commonly found example of a 
mechanism to defend against invading foreign genomic material. Similarly, the acquisition of 
nutrients from the environment is thought to have been accompanied by the emergence of 
rudimentary mechanisms, which helped distinguish between self and non-self, and which 
preceded more complex innate immune systems. However, the appearance of the adaptive 
immune system is relatively recent on the evolutionary time scale (Figure 1.1). 
 Investigators of the immune system have traditionally distinguished between innate and 
adaptive immunity. The former allows for a rapid, stereotyped, and largely nonspecific response, 
while the latter directs a less rapid but more specific response, typically within a multicellular 
organism, with the added feature of a “memory” of the response-eliciting agent, should it be 
encountered again. Adaptive immunity is thought to have first appeared in jawed vertebrates 
around 550 million years ago (Figure 1.1), though new discoveries have suggested its presence in 
jawless vertebrates as well, perhaps by convergent evolution (Kaufman, 2010, Hirano et al., 
2011, Boehm, 2012). It is believed that these jawed animals were likely to have been predatory, 
and to have evolved to sustain the food-chain homeostasis by maintaining high predator-to-prey 
ratio and, consequently, having few offspring. According to this “offspring protection 
hypothesis,” the need to protect the few offspring they did produce may have provided the 
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mechanism (Flajnik and Kasahara, 2010). Another hypothesis stipulates that because the early 
vertebrates were so morphologically and functionally complex, they were more likely to occupy 
a wider variety of ecological niches, which would, as a consequence, expose them to a wider 
variety of pathogens. For this “habitat hypothesis,” habitat expansion, and the accompanying 
expanded pathogen exposure, may have been a strong selective drive in the evolution of early 
vertebrate immune systems (Hedrick, 2004, Boehm, 2012). A third hypothesis suggests that the 
habitat that the early vertebrates themselves provided to a host of non-pathogenic microbes may 
have helped shape the evolution of the adaptive immune system. This “mutualism hypothesis” 
posits that the novel, complex features specific to the immune system of early vertebrates 
favored the evolution of complex, reciprocally beneficial relationships between autochthonous 
flora and host organism. The metabolic windfall in nutrients or the protection from pathogenic, 
allocthonous flora may then have helped drive the evolution of the adaptive immune system in 
early vertebrates (Lee and Mazmanian, 2010, Boehm, 2012). 
 Though these three, non-mutually exclusive hypotheses help us understand how an 
immune system as sophisticated as the one we and most other mammals now possess may have 
arisen, they say little about the tradeoff that may have taken place. In particular, we know that in 
humans, a number of pathologies are intrinsically related to the immune system: allergies and 
hypersensitivities, proliferative and oncological disorders, and immunodeficiencies. The 
evolution of the adaptive immune system may offer some clues. The different immune 
diversification methods seem to have appeared in association with the activity of members of the 
cytidine deaminase family: in agnathans, segmental recombination of the leucine-rich repeats 
(LRR) of variable lymphocyte receptors (VLR) resulted from the combined activity of DNA 
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cytosine deaminases 1 and 2 (CDA 1 and CDA 2); in gnathosomes, somatic hypermutation 
(SHM), class-switch recombination (CSR), and gene conversion, are all initiated by activation-
induced cytidine deaminase (AID) (Figure 1.1) (Kaufman, 2010, Hirano et al., 2011, Boehm, 
2012). It therefore behooves us to better understand how cytidine deaminase activity and the 
principal actors of adaptive immune system reactions interact to achieve proper physiological 
events, as well as how they may contribute to immunopathologies. We shall do so once we 
briefly review the different cell types and functions of the immune system, discuss the molecular 
machinery behind adaptive immunity recombination reactions, and, finally, give a presentation of 
the relevance of our projects. 
 One final note, before we delve into the above: there is some poetic “justice” of the 
evolutionary kind (from our vertebrate perspective, at least), in realizing that the invasion of the 
immunoglobulin loci ancestor by transposons (along with genome-wide duplications) may have 
set in motion a series of selective events that resulted in the rise of the adaptive immune system 
of vertebrates, a system much better tailored against the vagaries of infection by epitope-altering 
invaders like viruses, which, of course, are themselves related to transposons (Flajnik and 
Kasahara, 2010). In other words, it’s as if the evolution of the adaptive immune system is the 
result of the invaded organism modifying and using the very weapons of the invader to fend off 
further invasions. An early pressure for the evolution of deaminase-type enzymes might have 
been to combat viral/transposon presence in the cell, a defense device which might have then 
become coöpted to diversify the transposon-invaded immunoglobulin loci ancestor. This might 
perhaps also give us an enhanced appreciation for the different nucleic acid tropisms of 
deaminases. 
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I.2. Cell Types and Functions of the Immune System 
I.2.1. Development of Myeloid and Lymphoid Cellular Lineages 
 Over evolutionary time, different cells have arisen, which deal directly with the immune 
response, by sensing pathogens, secreting cytokines, or neutralizing antigens. The cells 
implicated in these functions broadly fall into two lineages, which largely correspond to the two 
branches of immunity (Figure 1.2). Myeloid lineage cells derive from the common myeloid 
progenitor, and are as varied as erythrocytes, macrophages, and granulocytes; myeloid immune 
cells are typically involved with innate responses. Lymphoid lineage cells, including B and T 
lymphocytes, stem from the common lymphoid progenitor, and mediate adaptive immunity. Both 
myeloid and lymphoid lineages are part of the hematopoietic system and share a common 
ancestor, the pluripotent hematopoietic stem cell.  
 Hematopoiesis starts as early during mouse and human embryonic development as at the 
yolk sac stage, and continues in several locations throughout development and after birth, 
including the aorta, gonad, mesonephros (or AGM, a region neighboring the dorsal aorta at the 
level of the embryonic middle kidney), the placenta, the fetal liver, and finally, the thymus and 
the bone marrow (Müller et al., 1994, Galloway and Zon, 2003, Gekas et al., 2005, Ottersbach 
and Dzierzak, 2005, Inman and Downs, 2007, Orkin and Zon, 2008). It is at the fetal liver stage 
that the pluripotent hematopoietic stem cell (HSC) gives rise to both multipotent progenitors: the 
common myeloid progenitor and the common lymphoid progenitor (Orkin and Zon, 2008). The 
common myeloid progenitor in turn yields other multipotent progenitors: the megakaryocyte/
erythroid progenitor (which ultimately gives rise to red blood cells and megakaryocytes/
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platelets), the granulocyte/macrophage precursor (from which descend monocyte/macrophages 
and granulocytes, i.e., mast cells, eosinophils, and neutrophils), and the macrophage/DC 
progenitor (from which monocytes, some macrophages, and the common DC precursors derive) 
(Orkin and Zon, 2008, Liu et al., 2009, Geissmann et al., 2010). Several transcription factors are 
important in the various differential development programs. Among them, GATA-1, a member of 
a family of transcription factors that recognize the DNA consensus motif 5’-WGATAR-3’ (where 
W= A or T, and R = A or G), in particular, is crucial at different time points for several lineages, 
including: erythrocytes, megakaryocytes, mast cells, and eosinophils (Orkin and Zon, 2008). 
Another transcription factor, PU.1, which recognizes the purine-rich PU-box 5’-GAGGAA-3’, is 
necessary for the proper development of monocytes/macrophages and granulocytes (Orkin and 
Zon, 2008). 
 One important component of the myeloid lineage is the extensively heterogeneous class 
of cells discovered over 40 years ago by Ralph Steinman and Zanvil Cohn and called dendritic 
cells (DCs), based on their “branching” morphological appearance (Steinman and Cohn, 1973, 
Steinman and Cohn, 1974). DCs can be grouped based on their tissue residence status in two 
sets: lymphoid tissue or conventional DCs and non-lymphoid tissue DCs. Conventional DCs can 
be divided into two large groups (CD8α+ DCs and CD4+CD11b+ DCs), and are distinct from 
migratory DCs and plasmacytoid DCs. Plasmacytoid DCs are involved in type I interferon 
responses. Migratory DCs typically express either CD103 or CD11b, though they express both in 
the lamina propria. Moreover, DCs in the outer epidermal layer of stratified epithelia are termed 
Langerhans cells. Finally, inflammation can cause the appearance of inflammatory DCs derived 
from monocytes (Ganguly et al., 2013, Schlitzer and Ginhoux, 2014).  
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 The common lymphoid progenitor gives rise to T cells, B cells, and innate lymphoid cells 
(ILCs). ILCs constitute a class of effector lymphoid cells that do not undergo receptor 
rearrangement like T cells, and that bear markers typically found on some myeloid cells (Killig 
et al., 2014). ILCs are comprised of natural killer (NK) cells (type 1 ILC), type 2 ILC, and type 3 
ILC. While the description of the ILC2 and ILC3 groups is still in its infancy, NK cells have 
been investigated more deeply, and their MHC I-mediated surveillance of tumors and virally 
infected cells is well characterized (Vivier et al., 2008).  
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Figure 1.2. Development of myeloid and lymphoid compartments. Cells involved in the 
immune response derive from the hematopoietic stem cell (HSC). Hematopoiesis starts in 
utero. Shown here are the different immune cells (before further differentiation in the 
periphery) and their precursors, as well as the tissues in which they develop in the adult. HSC: 
hematopoietic stem cell; CMP: common myeloid progenitor; CLP: common lymphoid 
progenitor; MEP: megakaryocyte/erythroid progenitor; GMP: granulocyte/monocyte 
progenitor; MDP: monocyte/dendritic progenitor; Meg: megakaryocyte; RBC: red blood cell; 
Eos: eosinophil; PMN: polymorphonuclear cells (neutrophils); Mon: monocyte; pDC: 








 T cells, so-named because part of their development is done in the thymus, play a central, 
integrative role in the adaptive immune system reaction, particularly in activating B cells to 
produce antibodies against protein antigens. Some of the transcription factors that allow for the 
proper development of T cells (γδ T cells, αβ CD4+ T cells, αβ CD8+ T cells) include Notch and 
T cell factor-1 (TCF-1) (Orkin and Zon, 2008). αβ CD4+ T cells can further differentiate into T 
helper 1 (TH1), TH2, TH17, induced regulatory T cells (iTREG), and T follicular helper (TFH), 
whose role is crucial in aiding B cell activation in the germinal center reaction; these different 
subsets appear to be more plastic than initially thought, even if they still possess a distinctive 
transcription factor signature: T-bet for TH1, GATA-3 for TH2, RORγt for TH17, FOXP3 for 
iTREG, and BCL-6 for TFH (O'Shea and Paul, 2010). 
 This year marks the 50th anniversary of the recognition by Max Cooper, Raymond 
Peterson, and Robert Good that B lymphocytes constitute a cell lineage distinct from T cells 
(Cooper et al., 1965). Naturally, their seminal contribution was made possible in part by 
preceding discoveries, including findings that antibodies mediate humoral immunity, that 
antibodies are γ globulins (by the Department’s Elvin Kabat, then a postdoctoral fellow in 
Sweden), that plasma cells make antibodies, and that bursectomy compromises bird antibody 
production (Behring and Kitasato, 1890, Tiselius and Kabat, 1939, Fagraeus, 1948, Cooper, 
2015).  Since then, much more has been learned about B cells. These cells owe their name to the 
Bursa of Fabricius, a lymphoid organ where they develop in birds. In adult mice or humans, there 
are two broad subsets of B cells, B1 and B2, with B2 accounting for the vast majority of B 
lymphocytes (Dorshkind and Montecino-Rodriguez, 2007, Monroe and Dorshkind, 2007). B1 
cells, which make up about 1 out of every 20 B cells can be found in the spleen, the intestine, 
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and serous cavities (pleural and peritoneal cavities). Although they can be generated from the 
bone marrow, they are most efficiently derived from embryogenesis-stage progenitors and are 
thought of as innate immunity effector cells, since they respond to T cell-independent antigens 
(e.g. microbial carbohydrates), with B1-a cells spontaneously secreting IgM (for instance against 
encapsulated bacteria) and B1-b cells producing antibodies only after induction (Kroese et al., 
1992, Kantor and Herzenberg, 1993, Haas et al., 2005, Montecino-Rodriguez et al., 2006, 
Dorshkind and Montecino-Rodriguez, 2007, Monroe and Dorshkind, 2007).   
 B2 cells develop in the bone marrow. A number of transcription factors are essential for 
proper B cell development. Chief among them is paired box protein 5 (PAX5), which 
simultaneously helps activate B cell-lineage specific genes and contributes to the repression of 
genes that would favor other differentiation programs (Busslinger, 2004, Cobaleda et al., 2007). 
Additional players that are important include Ikaros, PU.1, E2A, EBF, and BCL-11a (Orkin and 
Zon, 2008). The AGM-originating HSC-derived precursor CLP first appears in the fetal liver and 
then seeds the bone marrow (Müller et al., 1994, Medvinsky and Dzierzak, 1996, Pieper et al., 
2013). At this stage, the progenitor B cell, or pro-B cell, will start undergoing recombination-
activating gene (RAG) 1 and 2 product-mediated scrambling of its immunoglobulin heavy and 
light chain loci. First, a diversity (D) and a joining (J) segments from the heavy chain locus will 
recombine to form a DJ segment, which will then be recombined to a cis-located variable (V) 
segment in early pre-B stage (Tonegawa, 1987). Functional, rearranged H chains can then be 
expressed into intracellular pre-BCR (B cell receptor) if their expression product can pair with a 
surrogate light chain composed of V-preB and λ-like proteins. RAG gene expression, which had 
transiently gone down is upregulated once again, with the beneficial effect of catalyzing light 
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chain locus (κ or λ) V and J rearrangement. Once a successful light chain locus VJ rearrangement 
has taken place, its light chain product replaces the surrogate light chain, resulting in the 
assembly of an immunoglobulin M (IgM) protein, which can be expressed on the  B lymphocyte 
cell surface. These IgM-expressing, immature B cells leave the bone marrow, reach the 
secondary lymphoid tissues, and produce cell-surface IgD BCRs by alternative splicing of a large 
mRNA that can also translate into IgM BCR, making them mature B cells (Flajnik, 2002). 
Mature B cells can then further differentiate into marginal zone B cells and follicular B cells, 
notably through the germinal center reaction (Pieper et al., 2013). The IFNβ-promoter 
transcriptional repressor B lymphocyte-induced maturation protein-1 (BLIMP-1) has been found 
— thanks in part to contributions from the Department’s Kathryn Calame — to play an essential 
role in the terminal differentiation steps of the B cell lineage into immunoglobulin-secreting cells 
(Martins and Calame, 2008). 
 Finally, older and recent findings have shed light on the suppressive capacity of B 
lymphocytes, particularly with the description of regulatory B cells (BREG cells) (Katz et al., 
1974, Neta and Salvin, 1974, Wolf et al., 1996, Fillatreau et al., 2002, Mizoguchi et al., 2002, 
Mauri et al., 2003, Mauri and Bosma, 2012). BREG cells, by secreting IL-10, TGF-β, and IL-35, 
mediate the immunosuppression of pro-inflammatory actors (e.g., TNFα-producing monocytes, 
IL-12-producing dendritic cells, pathogenic T helper cells), the induction of immunosuppressive 
T cells, and the maintenance of invariant natural killer cells (Rosser and Mauri, 2015). Although 
a BREG cell precursor has so far not been identified, it is believed that various BREG cell subsets 
can be induced in different immuno-inflammatory environments (Rosser and Mauri, 2015).  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I.2.2. Functions and Interactions 
I.2.2.1. Innate Role 
 More than being a mere simpler, coarser, more ancient alternative to the more 
sophisticated adaptive response, innate immunity plays a complex and central role in shaping the 
way the organism counters antigen intrusion. Charles Janeway put this concept forth almost 30 
years ago; it stipulates that the recognition of well conserved viral, bacterial, and fungal 
pathogen-associated molecular patterns (PAMPs) by pattern-recognition receptors (PRRs) 
belonging to innate immunity cells triggers an inflammatory response and innate response and 
activates the adaptive response (Janeway, 1989, Iwasaki and Medzhitov, 2015). PAMPs are 
found on the cell walls of bacteria or fungi, for instance, and in viral nucleic acid. PRRs are 
principally made up of 3 families: the Toll-like receptors (TLRs), the nucleotide-binding 
oligomerization domain (NOD)-, leucine-rich repeat–containing receptors (NLRs), and the 
retinoid acid-inducible gene 1- (RIG-I-) like receptors (RLRs). Additional PRRs include C-type 
lectin receptors (CLRs), absent in melanoma 2- (AIM 2-) like receptors, and intracellular nucleic 
acid sensors, such as oligoadenylate synthase (OAS) proteins and their homologue cyclic GMP–
AMP synthase (cGAS) (Janeway, 1989, Kawai and Akira, 2010, Rathinam et al., 2012, Wu and 
Chen, 2014, Iwasaki and Medzhitov, 2015). The different receptor classes have predilections for 
different PAMPs, help determine the kind of pathogen that the organism is facing, and therefore 
help steer lymphocytic reaction towards the most apposite response (Figure 1.3). 
 Pathogen detection can happen through two broad avenues: it can be structure-based or 
function-based. Structural features allow the organism to sense the presence of antigen in two 
ways: one is the more intuitive pattern recognition, the other is the less obvious missing self 
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recognition. Pattern recognition is an old strategy that can be divided into a cell-extrinsic branch, 
and a cell-intrinsic branch, although most PAMPs can be detected by both cell-extrinsic and cell-
intrinsic branches. Cell-extrinsic pattern recognition is mostly facilitated by the PRRs of 
macrophages and dendritic cells: TLR1, TLR2, TLR4, TLR5, TLR6, CLRs (such as mincle, and 
dectins 1 and 2) have evolved towards the detection of β-glucans, flagellin, glycolipids, 
lipopeptides, lipopolysaccharides, and lipoteichoic acids, which are all conserved bacterial and 
fungal cell wall components. TLR3, TLR7, TLR8, and TLR9, on the other hand have evolved 
towards the detection of viruses (Iwasaki and Medzhitov, 2015). Unlike the bacterial and fungal 
wall component detectors, which are expressed on the cell surface, these TLRs are expressed in 
endosomes.  
 The cell-intrinsic branch of pattern recognition for viral pathogens is mostly mediated via 
RLRs (for viral RNAs) and cytosolic DNA sensors (for viral DNA) (Rathinam and Fitzgerald, 
2011, Gurtler and Bowie, 2013, Wu and Chen, 2014, Iwasaki and Medzhitov, 2015, Yoneyama et 
al., 2015). Cell-intrinsic pattern recognition bacterial detection is thought to be more dependent 
on the invasiveness, viability, and replication of the pathogen (Vance et al., 2009, Sander et al., 
2011, Blander and Sander, 2012, Stuart et al., 2013, Iwasaki and Medzhitov, 2015). This branch 
includes nucleic acid sensors like cGAS, PRRs such as NOD1 and NOD2, and NLRs that detect 
cytosolic PAMPs; interestingly, the inflammasome complex may be induced by some virus- and 
bacteria-sensing NLRs, leading to inflammatory cytokine production of the interleukin 1 (IL-1) 
family (Lamkanfi and Dixit, 2012, Burdette and Vance, 2013, von Moltke et al., 2013, Iwasaki 
and Medzhitov, 2015). 
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 In addition to cell-extrinsic and cell-intrinsic pattern recognition, the organism can sense 
pathogen through another structural features-based approach: missing self recognition (Kärre et 
al., 1986). This is an evolutionary ancient method of distinguishing self and non-self and is used 
by natural killer (NK) cells, macrophages, and the complement system (Iwasaki and Medzhitov, 
2015). NK cells, for instance, rely on the sensing of cell-surface class I major histocompatibility 
complex (MHC-I) by their immunoreceptor tyrosine-based inhibitory motif- (ITIM-) containing 
inhibitory receptors to recognize and not kill non-stressed or virally non-infected cells; but after 
some viral infections, oncogenic changes, or other forms of stress, MHC-I molecules may be 
downregulated, precipitating their lysis by NK cells (Raulet, 2006). 
 Beyond pathogen recognition based on structural features, the innate immune system can 
also sense pathogen presence indirectly through the detection of changes in function that imply 
the presence of a pathogenic intruder, like cysteine protease excretion or basement membrane 
disruption (Chovatiya and Medzhitov, 2014, Iwasaki and Medzhitov, 2015). There are a few 
advantages to recognizing functional features, as opposed to structural ones (Iwasaki and 
Medzhitov, 2015). One is that it allows the detection of a wide spectrum of pathogens based on 
the common features of their various infectious processes, instead of necessitating a specific 
receptor for each. Another advantage is that it can complement the information garnered from 
structural features-based recognition to discriminate between pathogens and non-pathogens; this 
would be beneficial, for instance, in the choice of appropriate responses to commensal versus 
pathogenic bacteria, given that both can be sensed by structural features-based recognition. One 
third advantage is that functional features-based recognition may provide a fail-safe mechanism, 
for instance for organisms that lack the stereotyped components (bacterial wall fragments, etc.) 
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recognized by TLRs, CLRs, and other PRRs. This might be the case for multicellular parasites 
with no invariant PRR targets (Iwasaki and Medzhitov, 2015). One illustrative mediator of 
functional features-based pathogen detection is the Nod-like receptor family, pyrin domain 
containing 3 (NLRP3) inflammasome, which can be activated by both organelle ion channel-
forming viroporins and bacterial pore-forming exotoxins (Mariathasan et al., 2006, Martinon et 




























































Figure 1.3. Integration of innate & adaptive immune systems. Illustrated here is a two-wave 
response mounted against a pathogen.  In both type 1 immunity and type 2 immunity, 
lymphocytes bridge the sensing by dendritic cells/macrophages and epithelia at one end, and 
the effector cells at the other end of the response. High affinity, highly effective 
immunoglobulin production by B cells relies on interaction with TFH cells in secondary 
lymphoid tissues.
 The cells bearing these sensors of foreign material are strategically located around the 
organism; their activation will often notify the immune system of the kind and degree of threat 
that is posed by the pathogen, and will result in the mounting of an appropriate response (Iwasaki 
and Medzhitov, 2015). One such strategic location is the mucosal epithelium, or more precisely 
its luminal interface, as is the case for supra-epithelial phagocytes, such as luminal alveolar 
macrophages in the lungs, and luminal dendritic cell extensions in the lungs and intestines 
(Rescigno et al., 2001). Another location is the epithelium itself. The epithelial barrier, even 
when it is not the final pathogenic destination, is often breached by an invading pathogen, and 
can send valuable information to the immune system and initiate an immune response to ready 
the host for the possibility of viral dissemination (Saenz et al., 2008, Abreu, 2010, Hermesh et 
al., 2010, Iwasaki and Medzhitov, 2015). The third strategic location is the lamina propria, where 
dendritic cells, macrophages, and mast cells can also play a sentinel role, by detecting PAMPs 
and secreting cytokines to summon other leukocytes: basophils, eosinophils, neutrophils, and 
monocytes (Uematsu et al., 2006, Iwasaki and Medzhitov, 2015). Finally, pathogenic presence in 
the blood itself (the fourth location) is promptly detected by monocytes and neutrophils, and 
results in a full-on response and the stemming of pathogen spread by various ways, including 
enhanced monocyte phagocytosis, eosinophilic granule release, respiratory burst, bacterial 
entrapment by DNA extrusion, acute phase response protein production, and plasmacytoid 
dendritic cell- (pDC-) mediated systemic type 1 interferon response (Asselin-Paturel et al., 2001, 
Barchet et al., 2002, Brinkmann et al., 2004, Asselin-Paturel et al., 2005, Pecchi et al., 2009, 
Reizis et al., 2011, Thomas and Schroder, 2013, Iwasaki and Medzhitov, 2015). 
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Among the different  PRR-bearing cells,  DCs play an important,  coordinating role by 
activating  the  adaptive  immune  system.  Different  types  of  tissue-resident  DCs  have  been 
described: stratified squamous epithelium-resident CD207+ Langerhans cells, BATF3-dependent 
CD103+CD207+CD11b- and IRF4-dependent CD301b+CD207-CD11b+ dermis- and submucosa-
resident DCs, and intestine- and lung-resident CD103+CD11b+ DCs. Tissue-resident DCs migrate 
to a secondary lymphoid tissue (draining lymph nodes, spleen, and mucosa-associated lymphoid 
tissues), where they, along with lymphoid organ-resident CD8α+ and CD11b+ DCs, will help 
prime and shape adaptive immune system responses (Satpathy et al., 2012, Ganguly et al., 2013, 
Merad et al., 2013, Persson et al., 2013, Schlitzer et al., 2013, Briseno et al., 2014, Iwasaki and 
Medzhitov, 2015).
Some innate responses will elicit the release of a wave of cytokines with a direct effector 
result;  such  is  the  case  for  pDCs  and  type  I  interferons,  and  mast  cells  and  histamine, 
prostaglandins, and proteases (Iwasaki and Medzhitov, 2015). Oftentimes, however, the different 
innate  immunity  pathogen sensing  modalities  are  integrated  in  complex  and elegant  fashion 
(Figure 1.3). PRR-mediated responses by DCs and macrophages and PRR-less epithelial cell-
mediated responses can trigger the release of a first wave of cytokines, which cause various 
lymphocyte  subsets  to  release  a  second  wave  of  cytokines  targeting  effector  cells  such  as 
neutrophils  and  B  lymphocytes  (Iwasaki  and  Medzhitov,  2015).  It  is  at  the  level  of  this 
integration of information that the germinal center reaction occurs.
I.2.2.2. The Germinal Center 
 Innate support for the specific response of the adaptive immune system culminates when 
antigen is brought from the periphery hematogenously or lymphogenously to secondary 
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lymphoid tissues to be exposed to B cells residing in primary follicles, in a process that can be 
mediated by Follicular Dendritic Cells (FDCs) and that can ultimately result in the production of 
high-affinity antibodies against the offending antigen (Figures 1.4 and 1.5).  
 The production of specific, high-affinity antibodies has long been enigmatic in 
immunobiology. The theory of clonal selection and the description of lymphocyte receptor gene 
rearrangement allowed for a deeper understanding of the diversification of the immune repertoire 
(Burnet, 1976, Hozumi and Tonegawa, 1976, Bernard et al., 1978, Early et al., 1980). The 
discovery that immunoglobulin affinity for antigen increases with time and that V(D)J 
recombination is supplemented by additional somatic alterations to the immunoglobulin genes 


































Figure 1.4. Interactions between B and TFH cells. In the course of their encounter during the 
germinal center reactions, several signals are mediated: survival, proliferation, differentiation, 
antibody diversification, adhesion, attraction. Shown in white are the genes upregulated in B 
cells during the interaction. Shown in boxes are the cell-surface proteins involved in different 
signals. Finally, also shown are different cytokines produced by TFH lymphocytes in their 
interactions with B cells.
et al., 1970, McKean et al., 1984, Berek and Milstein, 1987, Victora and Nussenzweig, 2012). 
Affinity maturation is now understood to be the outcome of an iterative process, whereby 
sequential rounds of competitive and fine-tuning interactions between B and T lymphocytes 
result in the selection and proliferation of B cells producing immunoglobulins with high antigen 
specificity (Figure 1.4). These reactions take place in a micro-anatomical and functional structure 
first described over 130 years ago by Walther Flemming: the germinal center (Nieuwenhuis and 
Opstelten, 1984, Victora and Nussenzweig, 2012, De Silva and Klein, 2015). 
 The first 7 days of the germinal center reaction to a potentially dangerous antigen are 
divided into three stages. The early initiation stage, lasting about two days post immunization, 
starts when naive B cells see antigen and become activated. They leave the B cell-rich and FDC-
containing primary follicle and migrate to the interfollicular region, where they can come into 
MHC/TCR- and CD40/CD40L-mediated contact with activated T lymphocytes that have 
similarly left the T cell-populated T cell zone after encountering cognate antigen (Kerfoot et al., 
2011, De Silva and Klein, 2015). This first, long-lived encounter allows for the T cell to acquire 
a T follicular helper cell (TFH) profile and for the B cell to become more fully activated. From 
day 3 to day 4 after immunization, the immune reaction will be in its late initiation phase. During 
this period, TFH cells, and later, B cells, will leave the interfollicular region and will penetrate the 
follicle, where, in the presence of FDCs, B cells will start to proliferate, creating an early 
germinal center at the center of the follicle. As a result, the non-activated, resident B cells are 
displaced into forming a mantle zone around the early germinal center. This germinal center-
containing follicle is also referred to as the secondary follicle. The third and last stage is marked 
by the massive proliferation of germinal center B cells and the establishment of the mature 
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germinal center. This period also sees the appearance of a dark zone and a light zone. The dark 
zone contains a network of reticular cells similar to the FDCs, within which B cells continue to 
vigorously proliferate; it is so-named due to its histological features, in contrast to the less 
densely populated light zone, where B cells, FDCs, TFH cells, and macrophages are encountered 
(MacLennan, 1994, Victora and Nussenzweig, 2012, Bannard et al., 2013, De Silva and Klein, 
2015). 
 B cell centroblasts residing in the dark zone were once believed to move to the light zone 
to differentiate into centrocytes, before becoming plasma cells and exiting the germinal center 
(MacLennan, 1994). Mounting evidence now suggests, however, that the intragerminal 
movements of B cells between the two zones may be slightly more dynamic, in that B cells can 
re-enter the dark zone after exiting it once to go into the light zone (Figure 1.5) (Allen et al., 
2007, Hauser et al., 2007, Schwickert et al., 2007, Victora et al., 2010). B cells that have exited 
the dark zone can indeed access the light zone and be selected, if post-V(D)J genomic alterations 
to the immunoglobulin receptor variable region-encoding loci has resulted in higher binding 
affinity to the antigen. In the light zone environment comprised notably of TFH cells and FDCs, B 
cells with higher B cell receptor-binding ability to antigen internalize the latter with higher 
efficiency and present it more readily on their surface Major Histocompatibility Complexes 
(MHC). As a consequence, neighboring TFH cells activated against the same antigen interact 
through their own T cell receptors with the higher-affinity B cells and select these cells for 
proliferation and differentiation. Some of these selected light zone B cells, however, instead of 
differentiating into  memory or plasma cells, will recirculate into the dark zone, where additional 
rounds of alterations to the loci that encode the variable regions of their immunoglobulin 
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receptors can occur (Allen et al., 2007, Hauser et al., 2007, Schwickert et al., 2007, Victora et al., 
2010). These recirculating cells will therefore go through an additional round of proliferation and 
somatic mutation before re-entering the light zone, where they can get further selected. This 
iterative process ensures the preponderance of plasma and memory B cells producing antibodies 
with the most enhanced binding to the immunizing antigen. This newer account of secondary 
follicle dynamics highlights two important, novel aspects of germinal center B cells. One is the 
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Figure 1.5. The germinal center reaction. Naive B cells migrate through different secondary 
lymphoid tissue compartments in the course of the germinal center reaction. Illustrated here is 
the itinerary of a B cell as it is being stimulated in the spleen to undergo somatic hypermutation 
and class-switch recombination. Several outcomes are possible for a naive B cell going though 
the germinal center reaction: it can undergo apoptosis, or differentiate into a plasma cell, or a 
long-lived memory B cell, readying the organism for subsequent encounters with the same 
antigen. 
concept of recirculation, which helps explain the efficiency of the process that leads to highly 
specific antibody production. The second is the realization that the major force behind the B cell 
germinal center reaction (i.e., B cell selection and affinity maturation) is competition for TFH cell 
help before and during the germinal center reaction, as opposed to direct competition for antigen 
(Victora et al., 2010, Victora and Nussenzweig, 2012). 
 The interzonal dynamics of the germinal center reaction are accompanied by a variety of 
changes at the molecular level in the different stages. During the early initiation phase, antigen 
activation coincides with, or precedes, the activity of several key factors, among which B cell 
lymphoma 6 (BCL-6), Myocyte-specific enhancer factor 2B (MEF2B), Myeloid cell leukemia 1 
(MCL1), Interferon-regulatory factor 4 (IRF4), and Myelocytomatosis (MYC). BCL-6 in 
particular is crucial at this stage, since in its absence, or that of its repression domain 2 (RD2), 
pre-germinal center B cells no longer migrate into the follicle, as they fail to upregulate the dark 
zone B cell-expressed chemokine receptor CXCR4, and fail to downregulate the mediator of 
follicle exit sphingosine-1-phosphate receptor type 1 (S1PR1) (Allen et al., 2004, Caron et al., 
2009, Kitano et al., 2011, Huang et al., 2014, De Silva and Klein, 2015). The cross-talk between 
B cells and T cells would not be spared in the absence of BCL-6 either, since its levels in 
precursor B cells correlate with the integrin-mediated interaction of the two cell types (Cannons 
et al., 2010, Kitano et al., 2011). The role of MEF2B seems to be intimately linked to that of 
BCL-6, as it seems that MEF2B induces BCL6 expression (Ying et al., 2013). MCL1 is an anti-
apoptotic protein whose deletion impairs germinal center formation (Vikstrom et al., 2010). The 
role of IRF4 has not cogently been characterized yet. Peculiarly, evidence indicates that IRF4 
seems to both activate and repress BCL6 transcription (Saito et al., 2007, Ochiai et al., 2013). 
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Finally, MYC function is equally complex and not entirely defined; however, MYC does seem to 
be important, since its deletion in activated mouse B cells hinders germinal center formation 
(Calado et al., 2012).   
 Later in the initiation phase, while IRF4 expression decreases, MYC, MEF2B, BCL-6, 
and MCL1 are still expressed, and remain so for the rest of the germinal center reaction, except 
for MYC, which ceases to be expressed during the proliferation and establishment (De Silva and 
Klein, 2015). As the B cell differentiates into a quiescent, long-lived plasma cell or memory B 
cell, different factors are again involved and play important roles, namely BLIMP1, IRF4 and 
XBP1 for plasma cells, and BACH2, PAX5, and PU.1-IRF8 for memory B cells (Nutt et al., 
2015). 
 Much remain to be untangled to gain a fuller appreciation of the regulation of the 
germinal center reaction dynamics at a molecular level, though a general picture continues to 
emerge. A considerable amount of knowledge has been accumulated, however, about the 
genomic changes that take place during the germinal center reaction. The alterations of the heavy 
and light chain immunoglobulin loci are at the very center of the adaptive immune system, and 
also shed some light on B cell-origin pathologies.  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I.3. B-Cell Specific Lymphoid Immune System Reactions 
I.3.1. Somatic Hypermutation 
 When B cells emerge from the bone marrow as naive B lymphocytes, they have already 
undergone substantial alterations to the genes that encode the B cell receptor. Indeed, it is 
estimated that at the conclusion of RAG-mediated V(D)J combinatorial recombination, B cells 
have so diversified their immunoglobulin repertoire that they can now recognize an astronomical 
5 x 1013 different molecules — more than there are stars in the Milky Way (Pieper et al., 2013). 
Yet this primary repertoire only represents an anlage, the basis for further diversification at the 
behest of activation-induced cytidine deaminase (AID), the mutator enzyme of B cells, through 
somatic hypermutation (SHM). The increased Ig diversity will allow for selection of the B cells 
with the best suited set of alterations for antigen-binding and T-cell interaction. In a sense, SHM 
can be understood as real-time evolution, the molecular facilitator of affinity maturation.  
 Among the different genomic alterations described in B lymphocytes, SHM is thought to 
have appeared with the first jawed vertebrates, before isotype switching and gene conversion 
(Figure 1.1) (Kaufman, 2010). The concept of SHM was introduced about 45 years ago, when it 
was argued that the most parsimonious explanation to account for the pattern of variability in 
mouse light chains was the “generat[ion] by somatic spontaneous mutation and by sequential 
selection by antigen of single step mutants” (Weigert et al., 1970). Support for this proposal soon 
followed when it was shown through sequencing that mutations in mouse myeloma 
immunoglobulin genes were confined to the Ig variable region, though the constant region could 
be SHM-targeted as well if Ig constant region transcription was induced (Kim et al., 1981, 
Selsing and Storb, 1981, Peters and Storb, 1996, Storb, 2014). The realization that transcription 
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plays an essential role in SHM led to a model linking somatic mutation to transcription-coupled 
DNA repair (Peters and Storb, 1996). In this insightful model, mutations are catalyzed by a 
mutator factor coupled to the transcription machinery from initiation at the promoter region and 
causing mutations during polymerase pausing. That mutator factor was later identified as AID 
(Muramatsu et al., 1999). 
 The mutations of SHM are mostly single base pair substitutions (transitions more so than 
transversions) — though insertions and deletions are also observed — with rates of 10-5 to 10-3 
mutations per base pair per generation, or approximately 106-fold higher than elsewhere in the 
genome (Rajewsky et al., 1987, Longerich et al., 2006). Analyses in the immunoglobulin heavy 
chain locus variable region indicate that the mutations start appearing about 150 to 200 bp 
downstream of the transcription start site and can still be detected for another 1.5 kilobases, 
clustering at WRC/GYW hotspots (where W = dA or dT, R = dA or dG, Y = dC or dT), but 
without extending into the constant region (Li et al., 2004). 
I.3.2. Immunoglobulin Isotype Switching 
 Isotype switching is the replacement of one antibody heavy chain isotype by another, 
along with the attendant changes in effector capabilities of a B cell in a mechanism termed class-
switch recombination (CSR). CSR is thought to have first appeared with amphibians and land 
animals after SHM had already evolved (Kaufman, 2010). Isotype switching from IgM to IgG 
was first described in birds (Kincade et al., 1970). However, the original version of today’s 
prevailing CSR model was proposed about 8 years later (Honjo and Kataoka, 1978). 
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 CSR is a recombination process that takes place in proliferating B cells, usually during 
the protein antigen-triggered, T cell- and dendritic cell-assisted germinal center reaction, 
although T cell-independent recombination also occurs (Figure 1.6) (Hodgkin et al., 1996, Rush 
et al., 2005, Bergqvist et al., 2006). The heavy chain immunoglobulin (IgH) locus is composed of 
several constant (Cx) regions, each preceded by 1-12 kb-long, G:C oligomer-rich switch 
sequences (Sx, except for Cδ, which has a rudimentary Sδ-like , σδ recently shown to undergo 
CSR as well), and a promoter exon Ix (Saintamand et al., 2015). Concomitant with cytokine-
inducible sterile transcription from Ix promoters, CSR-initiating AID deamination activity at the 
donor, upstream Sµ switch sequence, and at a 65-160 kb downstream, acceptor switch sequence 
may result in the presence of contemporaneous double-stranded DNA breaks (DSBs) at both 
sites of mutagenic activity that are repaired mostly through canonical non-homologous end 
joining (NHEJ) of the donor and acceptor switch sequences, as the DNA sequence intervening 
between the two DSBs is looped out and excised. Rarely, a switch region other than Sµ will 
recombine with another, further downstream acceptor sequence. NHEJ is favored in part because 
of the low homologies between the different switch sequences and because it is a predominant 
repair pathway during the G1 phase, which is when donor and acceptor DSBs appear (Dunnick et 
al., 1993, Petersen et al., 2001, Schrader et al., 2007, Sharbeen et al., 2012, Khair et al., 2014). 
The less-well defined Ku-independent, microhomology-directed, alternative non homologous 
end-joining has recently been shown to be mediated by the DNA end-processing factor CtBP-
interacting protein (CtIP), while Mre11, Rad50, Sae2 have also been implicated in yeast studies 
(Yan et al., 2007, Mimitou and Symington, 2010, Boboila et al., 2012, Bunting and 
Nussenzweig, 2013). 
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tional and post-transcriptional regulatory mechanisms
are in place to control each step of its DNA mutator
activity. The activity of AID is regulated transcriptionally
(e.g., HoxC4 and NFkB) (Xu et al. 2012), post-transcrip-
tionally (miR-155 and miR-181) (de Yebenes et al. 2008;
Dorsett et al. 2008; Teng et al. 2008), and post-transla-
tionally (e.g., AID phosphorylation [Basu et al. 2005;
McBride et al. 2006, 2008; Pasqualucci et al. 2006;
Chatterji et al. 2007; Aoufouchi et al. 2008; Basu et al.
2008] and ubiquitination [Aoufouchi et al. 2008]) by
various factors, as outlined in Figure 5 and discussed in
other recently published reviews (Orthwein and Di Noia
2012; Vuong and Chaudhuri 2012). Biochemical assays
demonstrate that AID is a single-strand deaminase, re-
quiring transcription to create access to ssDNA at sites of
transcription bubbles and R loops (Chaudhuri et al. 2003;
Yu et al. 2003). In vitro cytidine deamination on T7
transcribed DNA templates reveals that a significant
level of deamination occurs on the physiological non-
template strand (G-rich strand). A very modest amount of
deamination occurs when the inverted G-rich strand (now
acting as the template strand) is transcribed (Chaudhuri
et al. 2003). Strand-specific analysis of reaction prod-
ucts from transcription-coupled deamination reactions
reveals transcription targets AID deamination in an
orientation-dependent fashion, with deamination prefer-
entially targeted to the displaced single strand of the R
loop (nontemplate strand) (Chaudhuri et al. 2003). How-
ever, analysis of ung!/! msh!/! mice (where ung is the
DNA base excision repair [BER] enzyme uracil DNA
glycosylase [UNG], and msh are mismatch repair
[MMR] factors that function in the spreading of AID-
initiated mutagenesis) indicates that in the absence of
UNG and MMR pathway components, there is no pref-
erence for AID targeting preferentially to the nontem-
plate over the template strand, suggesting that AID can
deaminate both strands of DNA with equal frequency
(Xue et al. 2006). The proposed mechanism by which Ung
and Msh2/6 propagate AID mutations during SHM and
CSR is shown in Figure 4 and discussed in much greater
detail in the next section.
Discovery of AID as ‘B-cell mutator factor’
AID was identified by subtractive hybridization cloning
of cDNA expressed in mouse intestinal CH12F3 lymphoma
cells before and after stimulation for CSR (Muramatsu
et al. 1999). These experiments revealed increased ex-
pression of a novel gene in the stimulated sets of CH12F3
cells, and this gene was named activation-induced cyti-
dine deaminase (AID). The ORF of the AID cDNA
encodes a protein of 198 amino acids (or 24 kDa), with
Figure 3. Schematic of CSR intermediate steps in B cells. Transcription of various S sequences, in this case IgSm and IgSe, leads to
generation of secondary DNA structures that are substrates of the ssDNA cytidine deaminase AID. AID-mediated DNA deamination
leads to generation of DNA DSBs that are intermediates in a DNA deletion–recombination reaction, leading to completion of CSR.
Recombination between S sequences leads to deletion of intermediate DNA sequences that loop out as a circle. In this case, the IgSm
recombines with the downstream IgSe, with the intermediate sequence shown to be looped out, leading to IgE CSR. B cells with this
configuration of their IgH locus will be able to synthesize IgE. The details of each step in this illustration are discussed in the text.
Regulation of B-cell somatic mutations
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Figure 1.6. Class-switch recombination. The immun globulin heavy- and light- hain loci 
undergo RAG1/2-mediated V(D)J recombination as B a d T cells develop in the bone 
marrow. Mature B cells are capable of an additional deletion and end-joining process that 
results in their producing differently enabled immunoglobulin proteins. Shown here is 
isotype swit hing to IgE, an important effector against helminthic fections. IgA is s creted 
as a dimer at mucosal sites (e.g., gastro-intestinal tract); IgG, found in the blood, is a potent 
opsonizer.
 The different immunoglobulin isotypes feature well-characterized properties that confer 
specific effector functions to the B cell that produces them. For instance, IgM can be produced in 
pentameric form and is a strong complement system activator; IgA, secretable as a dimer across 
mucosal barriers, is crucial in keeping at bay pathogenic antigen; IgG is found in the blood (in 
subsets named for their relative abundance 1 through 4) and plays an essential role in 
opsonization and gestational and perinatal immunity; IgE, finally, is involved in granulocyte 
sensitization and protection against helminths. Depending on the port of entry, pathogenicity, and 
nature of the instigating antigenic insult, an assortment of cellular mediators is involved and a 
cocktail of cytokines is produced by epithelial and innate immune cells, influencing the germinal 
center milieu and shaping isotype choice in CSR. The B lymphocyte’s CD40, Toll-like receptor 
(TLR), and immunoreceptor tyrosine-based activation motif (ITAM)-containing protein complex 
CD79-associated B-cell receptor pathways integrate primary stimuli from T cells (e.g., CD40-
ligand CD154 on TFH cells) or antigen, resulting in the activation of nuclear factor-κB (NF-κB) 
through both its canonical and non-canonical modalities (Xu et al., 2012). NF-κB induces the 
expression of homeobox protein C4 (HOXC4); HOXC4 and NF-κB then induce the expression 
of the master mutator AID-encoding AICDA. In parallel, secondary signals carried by cytokines 
such as interleukin 4 (IL-4), transforming growth factor β (TGF-β), and interferon γ (IFNγ), up-
regulate transcription at the appropriate  Ix-Sx-Cx transcriptional unit (Xu et al., 2012). Finally, 
and interestingly, chromosome capture techniques have been employed to show that 
chromosomal looping, involving notably the IgH 3’ regulatory region and the intron enhancer Eµ, 
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plays a role in isotype selection (Wuerffel et al., 2007, Sellars et al., 2009, Chatterjee et al., 2011, 
Kenter et al., 2012, Stavnezer and Schrader, 2014).    
I.3.3. Gene Conversion 
 In some animals, most notoriously the chicken but also the rabbit, the product of V(D)J 
recombination is further altered by a process known as somatic gene conversion (Dildrop et al., 
1982, Kleinfield et al., 1986, Reth et al., 1986, Reynaud et al., 1987, Reynaud et al., 1989). 
Upstream of functional variable light and heavy chain immunoglobulin loci in the chicken lie 
clusters of nonfunctional families of pseudogenes, termed ΨVL and ΨVH (Ratcliffe, 2006). 
Though lacking the signal sequences that would facilitate their participation in V(D)J 
recombination, these pseudogene V elements can nonetheless be used by B lymphocytes to 
increase the post-V(D)J diversity of their immunoglobulin receptors, as stretches from these 
pseudogenes get copied and pasted into the functional V(D)J exon, in a B cell deaminator AID-
dependent diversification reaction, much like SHM and CSR (Arakawa et al., 2002, Fugmann 
and Schatz, 2002). Gene conversion represents another vertebrate mechanism to facilitate 
adaptive immunity by increasing B cell receptor diversity. AID requirement in this process might 
inform current and future investigations of the biology of its involvement in the adaptive immune 
system diversification schemes of murine and human B lymphocytes.  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I.4. Pathophysiology of B-cell Diseases 
I.4.1. Immunoglobulin Production-Related Immunodeficiencies 
 Given the prominent function occupied by B lymphocytes in adaptive immunity, it comes 
as no surprise that B cell disorders are likely to negatively impact the immune competency of an 
organism. In addition, processes taking place in other cell types, whose function is intimately 
related to antibody production by B cells, will have an effect on antibody synthesis. Primary 
immunoglobulin deficiencies can therefore have a B-cell intrinsic origin or a B-cell extrinsic 
origin. 
 B-cell originating immunoglobulin production defects can be classified into 6 broad 
categories: developmental defects, migration defects, survival defects, activation defects, 
cytokine responsiveness defects, and CSR defects. Inauspicious mutations in key proteins 
involved in B lymphocyte development have been associated with diseases such as 
agammaglobulonemias (many mutated proteins, among which: Bruton tyrosine kinase, BCR-
associated proteins CD79a and CD79b, and B cell linker protein BLNK), severe combined 
immunodeficiency (SCID, including adenosine deaminase (ADA), for which the first successful 
human gene therapy was conducted, RAG, adenylate kinase 2, and NHEJ components), 
dyskeratosis congenita, also known as Hoyeraal-Hreidarsson syndrome (which involves 
sheltering complex proteins), and the newly described dendritic cell, monocyte, B and NK 
lymphoid (DCML) deficiency or MonoMAC (monocytopenia with Mycobacterium avium 
complex), associated with GATA-2 mutations (Bigley et al., 2011, Durandy et al., 2013). B cell 
migration defects may be due to mutations in DOCK8 or MST1 (leading to combined 
immunodeficiency), WIP or WASP (leading to Wiskott Aldrich syndrome), CXCR4 (leading to 
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WHIM syndrome, for warts, hypogammaglobulinemia, infections and myelokathexis) (Durandy 
et al., 2013). B cell survival defects have been associated with mutations in the pro-inflammatory 
cytokine TWEAK (TNF-like weak inducer of apoptosis) and tumor necrosis factor receptors 
BAFFR/TACI (B-cell activating factor receptor/Transmembrane activator and CAML interactor), 
leading to common variable immunodeficiency (Durandy et al., 2013). B cell activation defects 
are numerous, and run the gamut from ICF syndrome (immunodeficiency, centromeric 
instability, facial anomalies, associated with mutations in DNA (cytosine-5-)-methyltransferase 
3β), to hypogammaglobulonemia related to CD19 or CD20 mutations, to combined 
immunodeficiency related to CARD11 mutations (caspase recruitment domain family, member 
11). Two other defects in this category include selective polysaccharide antibody deficiency 
(extensively disparate in origin) and PLCγ2-associated antibody deficiency and immune 
dysregulation. Described cytokine responsiveness defects include hyper-IgE syndrome and 
severe combined immunodeficiency (both associated with mutations in signal transducer and 
activator of transcription STAT3 and Janus kinase JAK3), as well as combined 
immunodeficiency resulting from IL21R mutations (Durandy et al., 2013). 
 Class-switch recombination defects have been associated with Ataxia-Telangiectasia, 
Nijmegen-breakage syndrome, and severe combined immunodeficiency; the proteins involved in 
these defects include important mediators of CSR: AID, CD40, UNG, PMS2, ATM, MRE11, 
NBS1, RNF168 (for AT and NBS), and NHEJ components for SCID (Durandy et al., 2013). In 
parallel to these B-cell intrinsic causes are B-cell extrinsic origins of immunoglobulin production 
deficiencies. Here, too, the defects can be categorized in 4 broad classes: T-cell differentiation 
defects, T-cell function defects, TFH defects, and innate immunity defects. In the first category are 
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found DiGeorge syndrome (caused in humans by a deletion in the long arm of chromosome 22) 
and combined immunodeficiency (in this case due to mutations in CD3 subunits or IL7Rα) 
(Durandy et al., 2013). Another form of combined immunodeficiency can be understood as 
deriving from T cell malfunction and is associated with mutations in the regulatory factors of 
MHC class II transcription, as well as the proteins ZAP70 (ζ-chain-associated protein kinase 
70) , ITK (interleukin-2-inducible T-cell kinase), and the protein tyrosine kinase p56Lck (Durandy 
et al., 2013). Defective TFH can be manifested by combined variable immunodeficiency (with 
mutations in ICOS, inducible T-cell costimulator), isotype switching defects (involving CD40 
ligand CD154 mutations), hyper IgE syndrome (if STAT3 mutations occur), and X 
lymphoproliferative and related disease (concomitant with mutations in CD27 or SAP, SLAM 
(signaling lymphocytic activation molecule)-associated protein) (Durandy et al., 2013). Finally, 
signaling defects in the TLR/IL1R pathways, due to mutations in IRAK4 (interleukin-1 receptor-
associated kinase 4), TLR and IL-1 adapter protein MyD88 (myeloid differentiation primary 
response 88), or TIRAP (toll-interleukin 1 receptor (TIR) domain containing adaptor protein), 
can induce innate immunity defects leading to B cell extrinsic primary antibody production 
deficiency (Durandy et al., 2013).  
I.4.2. B Lymphocyte-related Immunoproliferative Disorders 
 Lymphocytes, B cells in particular, have a certain predilection for oncogenic 
transformation. It is the evolutionary cost paid for having a system capable of massive 
proliferation (e.g., in the germinal center) and directed mutagenesis (RAG-mediated 
recombination, but especially AID-initiated alterations). This unfortunate oncogenic trade-off can 
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therefore typically manifest itself at times that coincide with the different B-cell development 
stages and immunoglobulin diversification reactions. 
 During B-cell lymphopoiesis in the bone marrow, a translocation involving the 
breakpoint cluster region (BCR) and the Abelson tyrosine-protein kinase homologue 1 (ABL1) 
and producing the “Philadelphia Chromosome” in precursor B cells can result in B cell acute 
lymphocytic leukemias (B-ALLs); additional sources for these leukemias involve mutations or 
translocations targeting runt-related transcription factor 1 (RUNX1)-associated mutations, pre-B 
cell leukemia homeobox 1 (PBX1), paired box protein 5 (PAX5), mixed-lineage leukemia (MLL), 
early B cell factor 1 (EBF1), transcription factor E2A, protein tyrosine phosphatase non-receptor 
type 11 (PTPN11), and Rat sarcoma (RAS) genes (Rickert, 2013). These genes play 
physiologically important roles in B cell differentiation and pre-BCR signaling, a crucial 
component of the proliferation/survival signal received by these cells.  
 Later on in primary follicles of secondary lymphoid tissues, mature B cells can give rise 
to mantle cell lymphoma (MCL, associated with mutations in cyclin D1 CCND1) and the non-
mutated form of B cell chronic lymphocytic leukemia (B-CLL), where the variable region has 
not undergone SHM (Seifert et al., 2012, Rickert, 2013).  
 In the marginal zone, mutations in NOTCH2 have been associated with splenic marginal 
zone lymphoma. Another lymphoma thought to originate from marginal zone B cells is mucosa-
associated lymphoid tissue (MALT) lymphoma, and mutations in the protein B cell lymphoma 
10 (BCL10) locus and mutations/translocations involving the protease mucosa-associated 
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lymphoid tissue lymphoma translocation protein 1 (MALT1) are thought to contribute to the 
development of this indolent lymphoma (Rickert, 2013). 
 B cells that undergo SHM and/or CSR in the germinal center secondary follicle can give 
rise to a number of neoplasms. Follicular lymphoma, diffuse large B-cell lymphoma, and 
Burkitt’s lymphoma derive from germinal center B cells, while memory B cells are thought to be 
the origin of the immunoglobulin variable-region mutated version of B-CLL, and plasma cells 
may give rise to multiple myeloma. Multiple myeloma has been associated with mutations in the 
transcription factor musculoaponeurotic fibrosarcoma (MAF), fibroblast growth factor receptor 3 
(FGFR3), interferon regulatory factor 4 (IRF4), and CCND1 (Rickert, 2013). The high 
proliferation rate of germinal center B cells, coupled to the genomic alterations occurring during 
that developmental stage, promote a particularly mutagenic environment, one that is mirrored by 
the multiplicity of neoplasms that can originate here. Both Burkitt’s lymphoma and follicular 
lymphoma have their origin in the dark zone of germinal centers. Translocations have been 
identified in variants of both lymphomas. In follicular lymphoma, a translocation thought to 
result from an error in RAG-mediated V(D)J recombination involves the immunoglobulin heavy 
chain locus (IGH) and the B cell lymphoma 2 (BCL2) protein locus. In Burkitt’s lymphoma, it is 
thought that mistakes arising during AID-mediated immunoglobulin heavy and light chain loci 
remodeling cause translocations, most notably between IGH and c-MYC. These translocation 
events are thought to juxtapose promoters or enhancers with an oncogene, causing the 
dysregulated ectopic expression of the latter (Basso and Dalla-Favera, 2015). In addition, 
Burkitt’s lymphoma is noteworthy for disruptions in phosphatidylinositol-4,5-bisphosphate 3-
kinase (PI3K) signaling, the regulatory axis composed by basic helix–loop–helix transcription 
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factor E2A and its negative modulator inhibitor of DNA binding 3 (ID3), and the Gα13 pathway, 
which negative modulates of GC B cell migration and PI3K signaling (Basso and Dalla-Favera, 
2015). In addition to the ectopic expression of BCL-2 resulting from the IGH-BCL2 translocation 
of follicular lymphoma, the genetic inactivation of the histone methyltransferase MLL2 is 
thought to play a fundamental role in the pathogenesis of this lymphoma (Basso and Dalla-
Favera, 2015). Diffuse large B cell lymphoma (DLBCL) is often described as coming in two 
subtypes: a germinal center B cell-like DLBCL (GCB-DLBCL) subtype, thought to originate 
from light zone B cells and an activated B cell-like DLBCL subtype (ABC-DLBCL), thought to 
originate from B cells later in the germinal center reaction (plamablasts). While the 
pathophysiology is not exactly ascertainable, certain unmistakeable  features can be highlighted. 
Gain-of-function mutations in the enhancer of zest homologue 2 (EZH2) seen in GCB-DLBCL 
are believed to drive epigenetic changes favorable to the lymphoma; in addition, translocations 
resulting in the ectopic expression of such oncogenes as BCL2 and MYC have also been noted. 
Moreover, Gα13 pathway inactivation is also observed in GCB-DLBCL (Basso and Dalla-
Favera, 2015). For ABC-DLBCL, one hallmark feature is the constitutive activation of the NF-
κB pathway; another feature is B lymphocyte-induced maturation protein 1 (BLIMP1)-encoding 
PRDM1 inactivation. Both ABC- and GCB-DLBCL display genetic aberrations thought to 
contribute to their pathogenesis, including BCL6 constitutive expression, inactivation of CREB-
binding protein-encoding CREBBP or E1A-binding protein p300-encoding EP300, inactivation 
of MLL2, and immune escape as a result of mutations in the genes encoding β2 microglobulin, 
HLA-A, B, and C. In addition to the above alterations, changes in ploidy can occur and confer 
neoplastic potential to the different B cell developmental stages (Basso and Dalla-Favera, 2015).  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I.5. Molecular Machinery of SHM and CSR 
I.5.1. AID and the APOBECs 
 The B cell-specific genome mutator enzyme activation-induced cytidine deaminase 
(AID) is a member of the APOBEC (Apolipoprotein B mRNA editing enzyme, catalytic 
polypeptide) zinc-dependent cytidine deaminase family of proteins (Figure 1.7) (Conticello, 
2008). The bona fide origin of the APOBECs is placed at about 500 million years ago, when 
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Figure 1.7. Evolution of APOBECs. While the evolution of APOBEC4 is not entirely 
understood, AID and APOBEC2 are the oldest APOBEC members, and appear as early as the 
first jawed vertebrates. APOBEC2 is found in muscle cells. APOBEC1, the apolipoprotein 
mRNA mutator behind the family name, appears to have evolved from AID around the time 
mammals appeared. The APOBEC3 subgroup is also thought tho have evolved from AID, 
though at a later time than APOBEC1, and are active in viral restriction.
Magor, 2004, Conticello et al., 2005, Zhao et al., 2005, Conticello et al., 2007)). Some 
APOBECs target RNA (e.g., APOBEC1), while others use DNA as their substrate (such as AID 
and the APOBEC3s). APOBEC1 plays an important role in lipid biology, as it edits the pre-
mRNA of apolipoprotein B100, deaminating a cytidine into a uridine and introducing a UAA 
stop codon, thereby allowing for the production of the shorter apolipoprotein B48 (Teng et al., 
1993). While APOBEC2 and APOBEC4 have been little characterized, members of the 
APOBEC3 genes (APOBEC3A to 3G) have been implicated in the control of primate retrovirus 
propagation (Jarmuz et al., 2002, Sheehy et al., 2002). Based on studies in yeast cytosine 
deaminase, a model for Zn-dependent deaminase catalytic activity was proposed, whereby the 
loss of the amino group is the result of a hydrolytic reaction by nucleophilic attack, in which 
participate the hydroxide of a Zn-activated water molecule and a glutamate found in the 
enzymatic catalytic pocket (Figure 1.8) (Ko et al., 2003, Conticello et al., 2007). 
 AID was discovered a little over 15 years ago through a subtractive hybridization screen, 
when cDNA from an activated B cell line was compared to that of the same cell line after 
cytokine stimulation to undergo in-vitro isotype switching (Muramatsu et al., 1999). It was 
shortly thereafter shown that post-V(D)J immunoglobulin remodeling through somatic 
hypermutation and class-switch recombination were abrogated in the absence of the deaminase, 
as AID-/- mice fail to undergo either genomic alteration event, and that gene conversion in 
chicken was similarly unable to take place (Muramatsu et al., 2000, Arakawa et al., 2002). The 
enzyme is relatively small at 198 amino acids (Figure 1.9). Its catalytic domain is contained 
between amino acids 55 and 94, though other domains, such as the SHM-required N-terminus 
and the CSR-required C terminus, and co-factors help regulate its function as well (Barreto et al., 
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2003, Ta et al., 2003, Chaudhuri and Alt, 2004, Shinkura et al., 2004, Ellyard et al., 2011, Ranjit 
et al., 2011). Although the only APOBEC family crystal structures available are those of 
APOBEC2 and APOBEC3G carboxy-terminal domain, a lot has been learned about AID by 
analogy to the other APOBECs (Prochnow et al., 2007, Chen et al., 2008, Conticello, 2008). 
However, and for a while, the target substrate of AID proved to be a controversial topic. Based 
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Figure 1.8. The deamination reaction. In the catalytic pocket of AID, a Zn atom is coordinated 
by 3 amino acids (2 cysteines and 1 histidine), and activates a water molecule that mounts a 
nucleophilic attack on the amine-bearing carbon of the deoxycytidine ring; this attack is 
facilitated by the participation of a glutamate residue, the carboxyl group of which is also 
depicted. At the end of the reaction, the amino group is lost, and the carbon is double-bonded to 
an oxygen atom.
on the deamination model of apolipoprotein B100 mRNA by APOBEC1, it was postulated that 
AID, similarly, used RNA substrates (MacGinnitie et al., 1995, Muramatsu et al., 2000, Steele 
and Blanden, 2001). In this model, AID, perhaps along with a substrate specificity-conferring 
cofactor, deaminates some mRNA, which can now encode a CSR recombinase or a somatic 
hypermutator, which in turn can deaminate Ig locus targets to initiate isotype switching or 
somatic hypermutation; in a variant of this model, AID-mutated Ig RNA is reverse-transcribed 
into DNA, from which RNA and eventually protein is made (Muramatsu et al., 2000). However, 
a number of studies have presented convincing evidence that physiological AID activity in B-cell 
immunoglobulin diversification is not on RNA but on DNA substrates. No reverse transcriptase 
in germinal center B cells has been described (Storb et al., 1999). AID was shown in vitro to 
catalyze the deamination of deoxycitidine residues on single-stranded DNA (Bransteitter et al., 
2003, Dickerson et al., 2003, Shen and Storb, 2004). Escherichia coli experiments confirmed this 
by showing that AID transformation of E.coli results in the presence of dC:dG transition 
mutations  on exposed single-stranded DNA in a transcription-enhanced phenomenon (Petersen-
Mahrt et al., 2002, Ramiro et al., 2003, Sohail et al., 2003). Finally, in vivo reports using 
glycosylase-deficient mice that replication of DNA undergoing SHM yields transition mutations, 
and recent comprehensive, high-throughput RNA sequencing observations from mouse models 
provide direct and conclusive support to the DNA-deamination model (Rada et al., 2002, Fritz et 
al., 2013). 
 Given the potentially deleterious effects that uncontrolled deamination activity could 
have, it is to be expected that AID activity regulation mechanisms have evolved. AICDA 
(activation-induced cytidine deaminase, encoding AID) is expressed specifically in stimulated 
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secondary lymphoid tissue B cells (Muramatsu et al., 1999). Though AID substrate DNA is 
nucleus-bound and the enzyme exhibits an N-terminus nuclear localization signal, AID is 
principally found in the cytoplasm, by virtue of a chromosome region maintenance/exportin 1 
(CRM1)-dependent, leucine-rich C-terminal nuclear export signal and a cytoplasmic retention 
mechanism, and its nuclear import being an active, energy-dependent transport (Ito et al., 2004, 
McBride et al., 2004, Geisberger et al., 2009, Patenaude et al., 2009). There are several 
additional ways in which the expression and function of AID are regulated. Nuclear AID can be 
polyubiquitinated, precipitating its degradation and shortening its half-life compared to 
cytoplasmic AID (Aoufouchi et al., 2008, Delker et al., 2013). AID can be phosphorylated at 
different residues, chief among them Ser38, but also Ser3, Thr140 and Tyr184; Ser38 
phosphorylation by the holoenzyme protein kinase A is important for CSR and SHM, as it 
mediates interaction with the heterotrimeric replication protein A (RPA), a single-stranded DNA-
binding protein (Figure1.9) (Chaudhuri et al., 2004, Basu et al., 2005, McBride et al., 2006, 
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Figure 1.9. Domain structure of AID. The potent single-stranded DNA mutator is tightly 
regulated. It contains a nuclear localization signal at its amino terminal, and a nuclear export 
signal at its carboxy- end. Also highlighted are residues that get phosphorylated. The kinase 
PKA catalyzes the phosphorylation of AID at its serine 38 residue, allowing it to interact with 
RPA and bind single strands of DNA at its SHM and CSR target loci.  
reported to regulate AID levels in B cells: heat shock protein 40 (HSP40) family member, J 
domain-containing DnaJa1 in its farnesylated form is necessary for physiological folding and 
levels of AID as well as for CSR (Orthwein et al., 2012); the ubiquitin- and ATP-independent 
protein degrader REG-γ, deficiency of which increases AID and CSR levels (Uchimura et al., 
2011); RNA polymerase-associated factor PAF1, as well as RNA splicing factors CTNNBL1 and 
SRSF1, defects in which negatively impacts CSR, physiological AID levels in the nucleus, and 
somatic hypermutation, respectively (Ganesh et al., 2011, Kanehiro et al., 2012, Willmann et al., 
2012). Finally, AID levels are also impacted more directly at transcription levels by E protein 
transcription factors (helix-loop-helix protein Id3 overexpression antagonizes AICDA 
expression), and post-transcriptionally by micro RNAs (miR-181b and miR-155) (Sayegh et al., 
2003, De Yébenes et al., 2008, Dorsett et al., 2008, Teng et al., 2008). 
 Mature B lymphocytes express higher levels of AID protein upon stimulation in vivo and 
in vitro (Muramatsu et al., 2000). AID deaminates cytidine residues on transcribed IgH switch 
regions (in CSR) or transcribed IgH or IgL variable regions (in SHM), a reaction that effectively 
“turns” the cytidines into uridines (Petersen-Mahrt et al., 2002, Neuberger et al., 2003, Di Noia 
and Neuberger, 2007, Maul et al., 2011). Post-deamination, several, non-mutually exclusive 
options, are available (Figure 1.10). First, during replication, the uracil could be read as a 
thymine by DNA polymerase, leading ultimately to a transition from dG:dC base-pair to a dA:dT 
base-pair. Also, the dU, which is present as a result of AID activity, can be the substrate of 
Uracil-DNA Glycosylase isoform 2 (UNG2) (Kavli et al., 2005). UNG2 enables uracil base 
removal by catalyzing the hydrolysis of the N-glycosidic bond (Ide and Kotera, 2004). This 
creates an apyrimidinic site. If UNG2 activity, which most often appears in the initial steps of the 
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base excision repair (BER) pathway, is instead directly followed by replication across the 
apyrimidinic site, then both transitions and transversions can occur, as each one of the four DNA 
nucleotides could be incorporated where the uracil base was once found (Chaudhuri et al., 2007). 
A third option implicates the MSH2/MSH6 complex from the mismatch repair (MMR) pathway. 
This complex could, in the course of dU:dG mismatch processing, introduce single-stranded 
gaps, the filling of which, by error-prone polymerases (e.g., polymerase η), could usher in further 
mutations (Li et al., 2004, Wilson et al., 2005). These options could explain SHM; but for CSR, 
it is predicted that UNG2 activity is succeeded by that of the apurinic/apyrimidinic endonuclease 
1 (APE1, also a BER pathway member), which will break the phosphodiester bond that UNG2, 
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Figure 1.10. Cellular responses to AID deamination. The product of the AID-catalyzed reaction 
is processed through various low-fidelity pathways in B lymphocytes resulting in the 
diversification of both the binding and effector abilities of immunoglobulin proteins. Phase 1 
SHM results from replication across a mismatch dU:dG or across an abasic site; Phase 2 SHM 
involves the mismatch repair (MMR) pathway, and induces patch repair. CSR may result from 
the engagement of the base-excision repair (BER) pathway, including the glycosylase UNG2 
and the endonuclease APE1. Low levels of CSR are witnessed in the absence of this pathway, 
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being a monofunctional glycosylase, could not disrupt, and create a nick in the switch region 
(Petersen-Mahrt et al., 2002). AID, though a single-stranded DNA deaminase, deaminates both 
the transcribed and the non-transcribed DNA strands (Milstein et al., 1998, Shen et al., 2006, 
Xue et al., 2006). If these nicks and/or gaps occur temporally and spatially closely enough, and 
on both DNA strands, then they could result in a DSB. This is referred to as the Neuberger 
model, in honor of the late Cambridge University immunologist and chemist. 
 CSR is thought to result from the recombination of a donor and an acceptor switch-
sequence DSBs principally through non-homologous end-joining (NHEJ) (Stavnezer and 
Schrader, 2014). NHEJ and homologous recombination (HR) represent the two main pathways 
cells use to repair DSBs; which pathway is taken seems to hinge on the cell cycle and the 
availability and the relative abundance of the proteins needed to steer DNA repair along the 
pathway. HR uses the sister chromatids of replicated DNA strands as homologous templates to 
engineer repair, while NHEJ allows the synapsis of two DNA strands with little or no homology. 
While HR operates during the S and G2 cell cycle phases, NHEJ predominantly occurs during 
G1 (Symington and Gautier, 2011). Following the generation of a DSB, the initiation of resection 
to reveal homologous sequences suitable for HR signals commitment to this pathway. Resection 
is more pronounced during S/G2 than in G1, and this would help explain why NHEJ is the B 
cell-favored repair pathway in the G1-restricted CSR; furthermore, S regions display a lack of 
sufficient homology to undergo successful homologous recombination (Dunnick et al., 1993, 
Petersen et al., 2001, Schrader et al., 2007, Stavnezer et al., 2008, Symington and Gautier, 2011, 
Sharbeen et al., 2012, Khair et al., 2014) .  
"43
 NHEJ requires the coordinated activities of several important proteins. DNA-dependent 
protein kinase (DNA-PK) is formed by the Ku heterodimer (Ku70 and Ku80) associated with 
DNA-PKcs (catalytic subunit) and is thought to bind DSB ends first due to the relative 
abundance of Ku (Stavnezer et al., 2008). Another complex, formed by MRE11, NBS1, and 
RAD50 (MRN complex) is also thought to rapidly bind to DSB ends and serve to assist in 
tethering them together. Additionally, the nuclease ARTEMIS associates with Ku and processes 
DNA ends, while the kinase ATM (ataxia telangiectasia mutated) is recruited and activated by 
MRN, and, in turn, phosphorylates several other proteins including NBS1, 53BP1, P53, CHK2, 
MDC1, and H2AX; this leads to more MRN accumulation, as well as the activation of cell-cycle 
checkpoints. Finally, Ku facilitates the binding of the ligase complex DNA ligase IV-XRCC4-
XLF, whose activity is necessary for the proper completion of the synapsis reaction (Stavnezer et 
al., 2008). 
I.5.2. AID Substrate-Targeting and in the Context of Chromatinized DNA  
 The faculty for AID to target its substrate sequences has long been the source of 
investigations. In cell-free assays, AID binds RNA but prefers DNA, even when it does not 
contain deoxycytidine residues, though the deamination reaction would only be observed on 
deoxycytidine-containing single-stranded DNA or transcribed double-stranded linear DNA 
(Chaudhuri et al., 2003, Dickerson et al., 2003, Pham et al., 2005, Ronai et al., 2007). It was also 
recognized that the enzyme had a proclivity for WRC/GYW motifs (where W = dA or dT, R = 
dA or dG, Y = dC or dT), since AID deamination was 4.6 times higher at these motifs than at 
coldspots during in vitro experiments, and 7.2 times higher at the same motifs than at coldspots 
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during in vivo experiments (Shapiro et al., 2002, Pham et al., 2003, Li et al., 2004, Larijani et al., 
2005, Chelico et al., 2009). 
 Despite the many regulatory mechanisms, at multiple levels, that help ensure AID activity 
is not promiscuous, several non-immunoglobulin genes have been reported as targets of somatic 
hypermutation or AID; an early example of such a gene is BCL6, which is found to be mutated in 
normal memory B cells as well as their diffuse large B cell lymphoma (DLBCL) counterparts 
(Pasqualucci et al., 1998, Shen et al., 1998, Pasqualucci et al., 2001). In addition, other non-Ig 
targets of AID have been identified, including PAX5 and PIM1, in DLBCL cells (Pasqualucci et 
al., 2004, Kotani et al., 2005, Okazaki et al., 2007). Another pathophysiological target of AID is 
c-MYC, the translocation of which with IGH is pathognomonic for Burkitt’s lymphoma; AID has 
been found to be required for the necessary double-stranded DNA breaks that lead to that 
translocation (Ramiro et al., 2004, Robbiani et al., 2008). It appears that non-Ig targets of AID 
may share similar sequence motifs as those present in physiological target enhancers, but that 
they are also more the subject of error-free repair than physiological AID targets (Liu et al., 
2008, Duke et al., 2013, Storb, 2014). 
 What has long been clearer is the role played by the chromatin milieu and state in 
general, and transcription in particular, to physiological AID activity. Transcription was initially 
implicated in AID-mediated immunoglobulin remodeling with the observation that in transgenic 
mice, immunoglobulin κ transcription enhancers were necessary for efficient somatic 
hypermutation, although the identity of the promoter did not matter much, since replacing the 
immunoglobulin-specific Vκ promoter with a β-globin promoter did not affect the ability of the 
cells to undergo SHM (Betz et al., 1994). It was thereafter shown that chromatin compaction as a 
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result of DNA hypermethylation of bacterial sequences inserted into Ig transgenes negatively 
impacts SHM, presumably because transcription is also negatively affected (Storb et al., 1996). 
Similarly, transcription through immunoglobulin heavy and light chain V(D)J exons or switch 
regions is required for SHM and CSR (Chaudhuri et al., 2007, Di Noia and Neuberger, 2007, 
Yang and Schatz, 2007, Maul and Gearhart, 2010). Observations that the constant region could 
be SHM-targeted as well if Ig constant region transcription was induced led to a model in which 
“a mutator factor that is present only in mutating B cells loads on to the transcription initiation 
complex assembled at the promoter and remains associated with the elongating complex” that 
will intermittently pause/stall, allowing for mutations to be catalyzed (Peters and Storb, 1996). 
AID was found to be the predicted mutating factor, and several additional co-factors were 
proposed, including replication protein A, protein kinase-Ar1α, and CTNNBL1, as well as, more 
recently, the non-coding immunoglobulin switch RNA generated following Lariat debranching 
(Chaudhuri et al., 2004, Basu et al., 2005, McBride et al., 2006, Pasqualucci et al., 2006, 
Conticello, 2008, Zheng et al., 2015). One important factor proposed in the last few years is 
suppressor of Ty 5 (Spt5 in yeast, SPT5 in human), a polymerase II pausing/stalling factor, which 
was found to interact with AID and to be required for physiological CSR (Pavri et al., 2010). The 
proposal of this protein as a cofactor of AID activity tentatively helped explain the mutation 
distribution profile of AID at its target sequences. Another important factor recently described is 
the RNA exosome complex (Basu et al., 2011, Pefanis et al., 2014, Pefanis et al., 2015). 
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I.5.3. The Ig R-Loop Reaction: RNA exosome and Senataxin 
 The implication of transcription in immunoglobulin remodeling strategies was all the 
more appreciable, because it helped reconcile in part the observation that AID is a single-strand 
DNA deaminase lacking activity on double-stranded DNA with the observation that both the 
template and the non-template DNA strands get mutated (Chaudhuri et al., 2003, Dickerson et 
al., 2003, Ramiro et al., 2003, Sohail et al., 2003). It was therefore proposed that the transcription 
reaction, by temporarily melting the DNA duplex and separating the two strands, exposes at least 
the non-transcribed strand to AID deamination activity. Indeed, mammalian switch region 
transcription results in the appearance of structures called R loops, that are formed when the 
RNA product of transcription hybridizes to the transcribed DNA and displaces the non-
transcribed strand. 
 I.5.3.1. R Loops 
 Short RNA:DNA hybrids can be seen in different physiological processes, as ~10 base 
pair-long primers for Okazaki fragments during DNA replication for instance (Sakabe and 
Okazaki, 1966, Okazaki et al., 1968, Egli et al., 1992, Waga and Stillman, 1998). During 
transcription, an ~8 bp-long RNA:DNA hybrid can be found within the active site of the RNA 
polymerase (Nudler et al., 1997). The RNA strand and the transcribed DNA strand exit the 
polymerase through two different channels, which impairs their ability to remain base-paired 
(Westover et al., 2004, Costantino and Koshland, 2015). However, the negative supercoils that 
arise in DNA in the wake of transcription by pol II may unwind the two DNA strands to the 
"47
extent that the synthesized RNA is allowed to anneal back to the transcribed DNA strand, 
forming a stable, longer RNA:DNA heteroduplex, and displacing the non-transcribed strand (Liu 
and Wang, 1987, Aguilera, 2002, Gowrishankar and Harinarayanan, 2004, Li and Manley, 2006, 
Kim and Jinks-Robertson, 2012, Costantino and Koshland, 2015). The relevance of supercoils 
was underscored by reports that AID, through the formation of RNA polymerase II transcription-
generated supercoils, may be able to be active on both the transcribed and non-transcribed DNA 
strands of some transcribed plasmids (Shen et al., 2005, Besmer et al., 2006, Basu et al., 2011). 
 One additional feature favoring the stability of R loops is that thermodynamic 
investigation of RNA:DNA hybrids suggests that depending on base composition some 
heteroduplexes can be quite stable compared to their DNA homoduplex counterparts (Thomas et 
al., 1976, Chien and Davidson, 1978, Conn et al., 1999). What is more, evidence suggests that 
heteroduplexes in which the RNA moiety is purine-rich (as would be the case during 
transcription at immunoglobulin switch sequences) are more stable than heteroduplexes with a 
pyrimidine-rich RNA strand (Hung et al., 1994, Ratmeyer et al., 1994, Lesnik and Freier, 1995, 
Wang and Kool, 1995). Factors that are antagonistic to R-loop formation include in bacteria the 
coupling of transcription and translation, which limits the extent to which RNA finds itself naked 
and able to base-pair with the DNA template strand (Gowrishankar and Harinarayanan, 2004). 
Though transcription and translation occur in different cellular compartments in eukaryotes, 
naked nascent RNA is co-transcriptionally coated with proteins that mediate splicing, export into 
the cytoplasm, or secondary structure formation, which has the effect of not only decreasing 
relative amounts of available RNA in the nucleus, but also preventing the accumulation of naked, 
linear RNA, which would more easily anneal to DNA (Kim and Jinks-Robertson, 2012). Finally, 
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the superhelical stress-relaxing enzyme topoisomerase 1 (TOP1) holds R-loop formation in 
check (Tuduri et al., 2009, Kim and Jinks-Robertson, 2012). 
 The presence of regulatory mechanisms that prevent R-loop accumulation suggests that 
the latter may be problematic for the cell. Early evidence of negative consequences related to the 
presence of R loops in the form of genomic instability events comes from observations in the 
yeast hpr1 hyper-recombinant mutant phenotype, in which the THO-TREX complex of mRNA 
metabolism and export, of which HPR1 is a subunit, is no longer able to assemble RNA into 
ribonucleoproteins, promoting R-loop formation, impairment of transcription elongation (with 
the attendant collision conflicts with the replication machinery), and recombination (Chávez and 
Aguilera, 1997, Huertas and Aguilera, 2003, Li and Manley, 2006, Rondón et al., 2010, Kim and 
Jinks-Robertson, 2012). In chicken DT40 cells, too, a genomic instability phenotype was 
observed when serine/arginine-rich splicing factor (SRSF1) depletion resulted in splicing 
complex assembly defects, subsequent R-loop accumulation, and high levels of genomic 
rearrangements (Li and Manley, 2005, Kim and Jinks-Robertson, 2012). In general, it is believed 
that the stretches of single-stranded DNA that are exposed in R loops are less stable than double-
stranded DNA, and are at increased risk of transcription-associated mutagenesis (TAM), 
recombination (TAR), and double stranded DNA breaks (DSBs) (Beletskii and Bhagwat, 1996, 
Muers, 2011, Kim and Jinks-Robertson, 2012, Wimberly et al., 2013, Costantino and Koshland, 
2015). 
 A number of human pathologies have been associated more or less convincingly with R-
loop accumulation (Groh and Gromak, 2014, Costantino and Koshland, 2015). A well-defined 
example is Fragile X syndrome, the most common genetic form of mental retardation, in which 
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R-loop formation has been shown to increase with CGG trinucleotide repeat element expansion 
within the 5’untranslated region of the FMR1 (the fragile X mental retardation 1 gene), impairing 
the physiological expression of the protein and resulting in gene silencing (Colak et al., 2014). 
Another example concerns the neurodegenerative disorders amyotrophic lateral sclerosis and 
frontotemporal dementia, where another nucleotide repeat expansion (involving the 
hexanucleotide GGGGCC) favors the formation of R loops, leading to transcription abortion in 
the hexanucleotide repeat expansion region, and molecular cascades that lead to pathologies 
(Haeusler et al., 2014). Finally, R-loop accumulation and the genomic instability that results 
from it have been proposed as being involved in the pathophysiology of some cancers. The 
observation that depletion of tumor suppressor BRCA2 (which is mutated and inactivated in 
some breast cancers) leads to R-loop accumulation and DNA damage checkpoint activation 
suggests that BRCA2 may work to suppress cancer development in part by preventing R-loop 
accumulation (Roy et al., 2012, Bhatia et al., 2014, Costantino and Koshland, 2015). Similarly, 
increased activity levels of the recombinase RAD51 and the myeloproliferative neoplasm-related 
FIPL1 in some cancers, may contribute to genomic instability, given that both these proteins 
promote RNA:DNA hybrid formation in yeast (Gotlib and Cools, 2008, Klein, 2008, Wahba et 
al., 2013, Costantino and Koshland, 2015). 
 The preceding deliberation notwithstanding, R loops have paradoxically also been shown 
to be involved in several physiological functions. The expression in the mouse-ear cress 
Arabidopsis thaliana of the long non-coding RNA cold-induced long antisense intragenic RNA 
(COOLAIR) regulates the flowering locus, and has been reported to be silenced by R-loop 
formation in the promoter region of COOLAIR (Sun et al., 2013b, Costantino and Koshland, 
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2015). Additionally, a link has been suggested between R-loop formation, chromatin compaction, 
and epigenetic modifications, notably H3S10 phosphorylation both in yeast and human cells, 
hinting at a the possibility of R loops as regulators of chromosomal structure (Skourti-Stathaki et 
al., 2011, Castellano-Pozo et al., 2013, Skourti-Stathaki et al., 2014, Costantino and Koshland, 
2015). Moreover, R-loop formation has been described at telomeric regions that produce the non-
coding telomeric repeat–containing RNA (TERRA); telomeric R-loop formation has been 
proposed to impede senescence in the budding yeast Saccharomyces cerevisiae by mediating 
telomere elongation in homologous recombination-competent telomerase mutant backgrounds 
(Balk et al., 2013, Costantino and Koshland, 2015, Cusanelli and Chartrand, 2015). 
 An additional, most important physiological function ascribed to R loops relates to their 
formation as a result of transcription at immunoglobulin switch sequences, where they can top 1 
kb in length (Daniels and Lieber, 1995, Tian and Alt, 2000, Shinkura et al., 2003, Yu et al., 
2003). R loop formation at switch sequences is thought to be favored in part by the asymmetric 
G-richness of the looped-out, non-transcribed DNA strand, which, unlike the transcribed strand, 
is hypothesized to be able to form stabilizing G-quadruplex DNA (G4-DNA) comprised by 
stacks of Hoogsteen hydrogen-bonded guanine quartets (Sen and Gilbert, 1988, Dunnick et al., 
1993, Yu et al., 2003, Duquette et al., 2004, Maizels, 2006, Kim and Jinks-Robertson, 2012). The 
looped-out, non-transcribed DNA finds itself in single-stranded conformation, and is a suitable 
target for AID activity, as evidenced in part by the isotype switching defect seen when the  G-
rich sequence is inverted or otherwise altered (Shinkura et al., 2003, Yu et al., 2003). This, 
however, does not fully address the question of how AID is able to access the transcribed DNA 
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strand, which also gets deaminated at immunoglobulin switch sequences (Milstein et al., 1998, 
Shen et al., 2006, Xue et al., 2006). 
I.5.3.2. The RNA Exosome Complex 
 These in vivo observations that AID deamination activity was present on both the 
immunoglobulin switch region transcribed strand and its non-transcribed base-pairing 
counterpart had stumped investigators for whom cell-free, biochemical assays had only helped 
explain transcription-mediated AID access to the non-transcribed strand (Chaudhuri et al., 2003). 
Even at physiological, R loop non-forming somatic hypermutation double-stranded DNA 
substrates, AID phosphorylated on its serine 38 residue by protein kinase A had been shown to 
access mainly the non-template strand (Basu et al., 2005, Chaudhuri et al., 2007, Basu et al., 
2008). Other experiments, involving the expression of exogenous AID in bacterial and yeast 
assays, revealed the prevalence of mutations on the non-template strand of transcribed substrates 
(Ramiro et al., 2003, Gómez-González and Aguilera, 2007). In the looped-out model for AID 
access to the non-transcribed strand, enzymatic deamination of the transcribed strand is 
seemingly impaired by the nascent RNA hybridizing to its template DNA and hiding it from 
mutagenesis. The absence of reports of AID deamination activity on hybrid RNA:DNA strands, 
or of evidence that the endoribonuclease ribonuclease H (RNase H) exposes switch sequence R-
loop template strands seemed to dash any hope of a parsimonious mechanistic explanation of the 
transcribed strand access problem (Yu and Lieber, 2003, Lieber, 2010). This changed when the 
RNA exosome complex was shown to target the catalytic activity of AID to both the non-
transcribed and the transcribed strands of transcribed duplex DNA substrates, initiating the 
generation of DNA double-stranded break intermediate substrates for constant region 
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immunoglobulin remodeling and chromosomal interactions (Wuerffel et al., 1997, Petersen et al., 
2001, Ramiro et al., 2004, Schrader et al., 2005, Robbiani et al., 2008, Basu et al., 2011). 
 The RNA exosome is a conserved, multi-subunit complex whose global architecture is 
seen under various forms in all domains of life (Figure 1.11). There are three classes of 
exoribonuclease catalytic activity: bacterial RNase II and RNase R, and eukaryotic ribosomal 
RNA processing protein 44 (Rrp44) have processive hydrolytic RNA decay activity; bacterial 
RNase D and eukaryotic Rrp6 possess distributive hydrolytic RNA decay activity; and, finally, 
bacterial and mitochondrial polynucleotide phosphorylase (PNPase) and the archaeal RNA 
exosome catalyze processive phosphorolytic exoribonuclease activity (Januszyk and Lima, 
2014). In eukaryotes, the RNA exosome is a ubiquitous endoribonuclease and 3′ → 5′ 
exoribonuclease composed of an RNA-binding, non-catalytic nine-subunit core similar in 
architecture to PNPase but sans its phosphorolytic activity (Exo9, composed of Csl4 (for Cep1 
synthetic lethal), Rrp4, Rrp40, Rrp41, Rrp46, Mtr3 (for mRNA transport 3), Rrp42, Rrp43, and 
Rrp45), which, depending on the subcellular localization, interacts with and regulates either or 
both catalytic subunits Rrp44 and Rrp6 (Mitchell et al., 1997, Allmang et al., 1999, Symmons et 
al., 2000, Anderson et al., 2006, Houseley et al., 2006, Liu et al., 2006, Oddone et al., 2007, 
Greimann and Lima, 2008, Lebreton et al., 2008, Schaeffer et al., 2009). Yeast studies suggest 
that in its cytoplasmic form, the RNA exosome complex is composed of Exo9 and Rrp44, while 
in the nucleus RNA exosome contains Rrp6 added to the Exo9-Rrp44 pairing found in the 
cytoplasm; finally, in human, a nucleolar complex is posited to be comprised of Exo9 and Rrp6 
(Mitchell et al., 1997, Tomecki et al., 2010, Wasmuth et al., 2014). The subunits comprising 
Exo9 form a pseudo-hexameric ring with RNA-binding activity inside the channel; the ring is 
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made up of three heterodimeric pairings: Rrp41-Rrp45, Rrp46-Rrp43, and Mtr3-Rrp42 (Januszyk 
and Lima, 2014). The ring is then bound by the heterotrimeric ring cap comprised of Csl4, Rrp4, 
and Rrp40, whose channel is continuous with that formed by the hexameric non-cap ring 
(Januszyk and Lima, 2014). It has been proposed that Rrp44 associates with the bottom of Exo9 
through interactions between its Rrp44 endoribonuclease-containing, N-terminal Pilus-forming 
N-terminus (PIN) and one of its cold-shock domains (CSD1) with core subunits Rrp41, Rrp45, 
and Rrp43; the same model also suggests that Rrp6 associates with the top of Exo9 through its 
Rrp6 C-terminal domain (6CTD) interacting with Csl4, Mtr3, and Rrp43 (Makino et al., 2013, 
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Figure 1.11. The RNA exosome complex. 
Illustrated here is the complex composed of 
its nine non-catalytic core subunits: the 3-
subunit cap in light grey, the 6-subunit ring in 
dark grey. The cap can bind RRP6, which has 
exoribonuclease activity; the bottom ring can 
associate with RRP44, which has both exo- 
and endo-ribonuclease active sites. 
current structural models points to a channel-containing, RNA-binding non-catalytic hetero-
nonamer, sandwiched by catalytic subunits (Makino et al., 2013, Januszyk and Lima, 2014). 
 The RNA exosome complex has been shown to interact with a number of factors that 
help it identify which RNA substrates to process/degrade. In yeast, RNA exosome participates in 
the  3′ → 5′ degradation of mRNA in the cytoplasm by interacting with the Ski complex and the 
translation machinery (Araki et al., 2001, Wang et al., 2005, Halbach et al., 2013, Januszyk and 
Lima, 2014). In the nucleus, RNA exosome has been shown to interact with Rrp47 (also known 
as C1D in human) via the catalytic Rrp6, and with Mpp6 to process RNA species like the 3’ 
extended version of the precursor to 5.8S rRNA (Mitchell et al., 2003, Schilders et al., 2005, 
Stead et al., 2007, Milligan et al., 2008, Costello et al., 2011, Januszyk and Lima, 2014). The 
nuclear RNA exosome has also been shown to interact with the TRAMP complex (Trf4/Trf5 
poly(A) polymerases, Air1/Air2 Zn-knuckle RNA-binding proteins, and Mtr4 RNA helicase) to 
carry out aberrant RNA degradation and surveillance (LaCava et al., 2005, Callahan and Butler, 
2010, Januszyk and Lima, 2014). One putative interaction is with the nuclear RNA exosome 
targeting (NEXT) complex (comprised, in its human iteration, of hMTR4, the Zn-knuckle protein 
ZCCHC8, and the putative RNA binding protein RBM7) to facilitate promoter upstream 
transcript degradation (Preker et al., 2008, Lubas et al., 2011, Januszyk and Lima, 2014). In 
addition to its interaction with AID, two other interactions of particular importance have been 
suggested (Basu et al., 2011). One is with the NNS complex (Nrd1, Nab3, and Sen1 — 
alternatively called the NRD complex), allowing the degradation and/or processing of several 
small nuclear and small nucleolar RNA polymerase II transcripts (Vasiljeva and Buratowski, 
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2006, Rondón et al., 2009, Januszyk and Lima, 2014). The other is with RNA polymerase II 
transcription elongation cofactors Spt5/6 (Andrulis et al., 2002). 
I.5.3.3. RNA in the Ig R-loop Reaction: RNA exosome, Stalling, and Senataxin 
 The RNA exosome complex proved to be a long-sought cofactor of AID targeting in post 
V(D)J B-cell genome AID-dependent remodeling reactions through in vitro and in vivo 
experiments (Basu et al., 2011, Pefanis et al., 2014). The RNA exosome complex is required for 
proper SHM substrate AID deamination activity on the non-transcribed and the transcribed DNA 
strands. The RNA exosome complex accumulates at the switch sequences of B cells activated to 
undergo isotype switching in an AID-dependent fashion, where it also associates with the 
mutator enzyme. CSR is severely impaired when the RNA exosome complex cannot function 
properly. 
 The successful production of functional antibodies necessitates full-length transcription at 
immunoglobulin loci and is required to avoid apoptosis (Liu et al., 1989). The presence of AID-
initiated alterations in these loci suggests that full-length transcription occurs after the DNA 
mutation events have taken place. In an updated model for AID activity at its physiological Ig 
substrates, the deamination events caused by AID occur when the mutator enzyme has 
successfully and stochastically been loaded onto a transcription machinery complex at the 
transcription start site, which becomes associated with transcription pausing/stalling factors; this 
would favor pausing of the complex, permit the degradation of the nascent RNA such that 
transcription is aborted and polymerase released, and allow AID deamination reactions on 
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exposed transcribed DNA (Figure 1.12) (Kuehner et al., 2011, Sun et al., 2013a, Storb, 2014). 
While the RNA exosome complex is thought to mediate the removal of the transcription product, 
SPT5 has been reported to associate with CSR-involved polymerase II at AID target sequences 
(Pavri et al., 2010). With SPT4, SPT5 forms a heterodimeric complex called 5,6-dichloro-1-β-d-
ribofuranosyl-benzimidazole (DRB) sensitivity inducing factor (DSIF), which, along with 
negative elongation factor (NELF), has been shown to interact with polymerase II and lead to 
pausing (Wada et al., 1998, Yamaguchi et al., 1999a, Yamaguchi et al., 1999b).  
 Elongating polymerase II complexes exist in several states (Adelman and Lis, 2012, 
Jonkers and Lis, 2015). The poised pol II pre-initiation complex near the transcription start site 
contains pol II as well as general transcription factors, is bound to the promoter, but has not 
started synthesizing RNA. The pol II complex can then become stalled, a term signifying that it 
is associated with pausing-inducing factors, such as NELF, DSIF, and transcript cleavage factor 
TFIIS, all of which are involved in pausing, arresting, or terminating transcription by the 
complex. Paused pol II is able to resume elongation, as the RNA is properly aligned in its 
polymerase active site, although the RNA 3’ end may have unraveled to a negligible degree, and 
RNA synthesis momentarily been stopped (Adelman and Lis, 2012). Arrested pol II has 
backtracked along the transcribed DNA such that the RNA 3’ end is no longer in place in the 
active site. Arrested pol II complex restart is possible but requires additional factors. The nascent 
RNA could alternatively become dissociated from the DNA template if the pol II elongation 
complex is too unstable, terminating transcription and releasing the polymerase, which can 
recycle at the promoter (Muse et al., 2007, Zeitlinger et al., 2007, Lee et al., 2008, Adelman and 
Lis, 2012).  
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 Some genomic regions are more prone to stalling, and transcription termination could 
help prevent the accumulation of paused RNA polymerase II complexes on the DNA (Anindya et 
al., 2007, Svejstrup, 2010, Sun et al., 2013a). It is thought that RNA pol II release from the 
template DNA strand can be precipitated by a polyubiquitination event that is initiated by a 
monoubiquitination reaction catalyzed by the homologous to the E6-AP carboxyl terminus 
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Figure 1.12. The Ig R-loop model. At IGH switch sequences, SPT5-mediated RNA polymerase 
II stalling/pausing and transcription-favored R-loop formation contribute to give AID access to 
its substrates in single-stranded DNA conformation. The RNA exosome complex, through its 
ribonuclease activity is a crucial co-factor of AID activity here, in part by recognizing the RNA 
3’ end exposed by backtracked polymerase, and helping remove/degrade it, to reveal the 
transcribed strand and make it susceptible to AID activity. Not depicted here is the hypothetical 
involvement of RNA/DNA helicase senataxin.
monoubiquitination of the lysine 63 residue of RNA pol II is followed by the polyubiquitination 
of RNA pol II K48 by a different enzyme (Harreman et al., 2009, Sun et al., 2013a). It was 
recently shown that pol II transcription complex at both noncanonical and CSR substrates of AID 
is ubiquitinated by NEDD4 (Sun et al., 2013a). NEDD4 activity at RNA exosome target 
sequences was shown to be required, linking pol II release from its DNA template to RNA 
exosome access to the nascent RNA 3’ end (Keim et al., 2013). 
 Yet, transcription termination of sterile transcripts at AID target sequences as a 
mechanistic step in antibody diversification is still not entirely elucidated. RNA:DNA hybrids 
that transiently appear during transcription are assembled into heteroduplex helices that vary in 
conformation depending on nucleotide content between A-form and B-form structures (Rich, 
1960, Furth et al., 1961, Egli et al., 1992, Egli et al., 1993, Hung et al., 1994, Ratmeyer et al., 
1994, Lesnik and Freier, 1995, Wang and Kool, 1995). To date, only hydrolytic ribonuclease 
catalytic activities have been described for the RNA exosome complex, leaving open the 
possibility that its activity is supported by a cofactor with helicase activity (Januszyk and Lima, 
2014). Reports that in yeast, Sen1 as a member of the Nrd1-Nab3-Sen1 NNS transcription 
termination/processing pathway that generates non-coding RNA, may be associated with the 
RNA exosome complex via Nrd1, or that SETX, the human homologue of Sen1, may be 
associated with the RNA exosome by interacting with RRP45, one of its nine core subunits, hints 
at the tantalizing possibility that a helicase might be involved in the transcription termination 
reaction steps that accompany AID-initiated mutations at Ig switch sequence transcription-
generated R loops (Vasiljeva and Buratowski, 2006, Rondón et al., 2009, Richard et al., 2013, 
Porrua and Libri, 2015).      
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 Sen1 was identified through a tRNA-splicing endonuclease activity screen almost 30 
years ago, which showed that mutations in Sen1 caused temperature-sensitive growth, reduced in 
vitro endonuclease activity, and in vivo accumulation of unspliced pre-tRNAs (Winey and 
Culbertson, 1988). Based on the sequence motif-based comparisons with other enzymes and the 
realization that a wider spectrum of RNA species are affected by defects in Sen1 activity, it was 
proposed that Sen1 is a RNA helicase member of the helicase superfamily I (SFI) (Koonin, 1992, 
Ursic et al., 1997). Later, more sophisticated analyses confirmed the SF1 classification of Sen1 
as a non-ring forming, DExxQ motif-containing, Upf1-like, ATP-dependent, 5’ → 3’ RNA and 
DNA helicase, with putative activity on RNA:DNA heteroduplexes akin to some members of the 
SF1 superfamily such as Pif1 (Boulé and Zakian, 2007, Fairman-Williams et al., 2010, 
Jankowsky, 2011). The discovery that the human orthologue of Sen1, senataxin (for Sen1 - ataxia 
- protein), is mutated in a loss-of-function manner in the neuromotor disorder ataxia with 
oculomotor apraxia type 2 (AOA2) was further evidence that RNA biogenesis, even of non-
coding species, plays an important role in cellular health (Figure 1.13) (Moreira et al., 2004, 
Fogel et al., 2009). Other disorders, most prominently, a juvenile form of Lou Gehrig’s disease, 
amyotrophic lateral sclerosis type 4 (ALS4), have since been associated with dominant mutations 
in senataxin (SETX) (Chen et al., 2004).  
I.5.4. Summary of Major Projects and Hypothesis 
 From the very start, investigators of adaptive immunity have wrestled with a central 
conundrum: how cells engineer a large number of varied antigen-binding proteins from a finite 
number of genes. Over the years, the discovery of immunoglobulin-gene recombination reactions 
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has considerably improved our understanding of that central question, particularly as it pertains 
to B lymphocytes.  
 Like T cells, B cells undergo antigen-receptor locus rearrangement through V(D)J 
recombination. Unlike T cells, they further modify their antigen receptor loci through the 
processes of Somatic Hypermutation (SHM) and Class-Switch Recombination (CSR), two 
physiological alterations initiated by the mutator enzyme Activation-Induced cytidine 
Deaminase (AID), whose expression is most distinctive in the Germinal Center-(GC) B cells of 
lymph nodes and the spleen. These three types of physiological, controlled damage to the DNA 
require transcription in order to proceed; and the recruitment of repair factors to sites of 
physiological DNA damage may depend in part on the transcript(s) produced and on the 
chromatin milieu.  
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Figure 1.13. Domain structure of SETX. The open reading frame for SETX is large (>8000kb) 
and includes 26 exons, though the first 2 do not code for proteins. Some reports suggest the 
presence of alternative transcription start sites in exon 10, and additional isoforms from 
differential splicing involving exon 24 and 25 (Fogel et al., 2009). Regions of homology 
between SETX and Sen1 are shown (protein interaction N-terminal domain; and carboxy-
terminal helicase domain and nuclear localization signal (NLS). Also shown are reported loss 
of function mutations in AOA2 and gain of function mutations in ALS4.
 The study of B cells is of great value, given that mutations in AID have been linked to 
immunodeficiencies, and that some oncogenic translocations in B-cell lymphomas have been 
associated with AID, highlighting the central place that the maintenance of the B-cell genomic 
organization occupies both physiologically and pathophysiologically.  
 In this context, we set out to investigate different aspects of the biological processes that 
are thought to contribute to the maintenance of B-cell genomic organization. In particular, the 
projects discussed below aim to elucidate the roles played by the RNA exosome and senataxin 
— by helping resolve RNA:DNA hybrids — in sustaining, and restricting, needed 
physiological genomic alteration reactions to suitable substrates and in preventing the 
generation of catastrophic mutagenic events.  
 RNA Exosome and AID-dependent B-cell genomic instability. AID, a single-stranded 
DNA deaminase, accesses both the template and the non-template strands of DNA in vivo. Our 
group has reported that the RNA processing/degradation complex RNA exosome enables AID 
access to both strands of DNA in B cells during CSR. Beyond its role in facilitating access to 
both DNA strands, we want to investigate the role played by the RNA exosome in targeting the 
mutagenic consequences of AID activity to its physiological substrates, thereby preventing 
genomic instability. Our hypothesis is that in the absence of the RNA exosome, AID sub- 
stoichiometrically accesses the RNA-hybridized template DNA strand; as a result, the non- 
template strand bears the brunt of AID deaminase activity. The product of this dysregulated 
activity may no longer be suitable for physiological recombination during isotype switching, but 
may instead prefer undergoing translocation events with non-physiological partners, such as the 
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proto-oncogenic c-MYC locus. In such a setting, the RNA exosome would indeed emerge as a 
protector of AID-mediated genomic integrity.  
 Senataxin and AID-dependent B-cell genomic instability. We set out to investigate the 
role that the RNA/DNA helicase senataxin (SETX) plays in the sequence of biological events 
that result in CSR. SETX is the human homologue of Sen1, a member of the yeast RNA/DNA 
helicase superfamily I. In yeast, Sen1 forms a complex with Nrd1 and Nab3 thought to bind 
RNA polymerase II, unwind the RNA:DNA hybrid, and therefore play an important role in 
transcription termination. One way this may occur is by the resolution of the R loops that are 
created at G-rich pause sites downstream of polyadenylation signals. We reasoned that SETX 
may have a similar role in the G-rich Ig switch sequences found in B cells, and that in its 
absence, the RNA:DNA hybrids may not be unwound, obstructing RNA exosome-mediated 
removal or degradation of sterile transcripts, and, ultimately, preventing AID access to the 
template strand. In this context, senataxin, like RNA exosome, would also play a role in 
guaranteeing that the genomic integrity of the cell is maintained.  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Chapter II: Materials and Methods 
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II.1. Materials 
II.1.1. Conditionally-Deletable RNA exosome Mouse 
 The recombined mouse designed by, and generated under the guidance of, Evangelos 
Pefanis, has several particularities that have been published (Pefanis et al., 2014). It contains at 
its ROSA26 locus a transgene encoding the Cre recombinase fused to the estrogen receptor T2. 
At the EXOSC3 locus, two pairs of mutually exclusive heterologous Cre substrate loxP sites 
flank the portion of the locus bounded by exons 2 and 3. In intron 3 are also inserted the inverted 
sequences for a splice acceptor, a T2A-GFP cassette, and a polyadenylation transcription 
termination signal. When Cre-mediated inversion occurs, involving two facing monads of either 
pair of lox sites, exon 1 can be spliced onto the splice acceptor, and transcription termination can 




















Figure 2.1 The EXOSC3 allelic inversion-deletion reaction. Cre recombinase activity on same-
orientation homologous lox sites can result in deletion of the intervening sequence, while Cre 
recombinase activity on opposite-orientation homologous lox sites can result in reversible 
inversion of the intervening sequence. When Cre-ERT2 is translocated into the nucleus, it can 
catalyze an inversion reaction between the 2 loxP sites or the 2 lox2372 sites. The pair involved 
in the inversion reaction will now have one of its sites flanked by the two sites of the pair that 
did not engage in the inversion reaction; the two lox sites that did not engage in the inversion 
reaction find themselves in the same orientation and can mediate the deletion of the intervening 
sequence, meaning they can now facilitate the deletion of one of the 2 lox sites involved in the 
preceding inversion reaction, preventing it from being reversible and locking in place the 
inverted conformation. Shown above is an example using the loxP sites as being involved in 
the inversion reaction, and the lox2372 sites as the ones mediating the deletion reaction.
possible between two homologous adjacent loxP sites and traps in the post-inversion 
conformation. The strategy is summarized in Figure 2.1. 
II.1.2. HB-GFP Construct 
 We are grateful to have received the construct for a recombined protein encoding the 
RNA:DNA Hybrid Binding domain of RNaseH1 which has been fused at its amino- end to a 
GFP tag (Bhatia et al., 2014). The backbone is the mammalian expression vector pEGFP-C1, 
which encodes kanamycin resistance for growth in bacteria at 30 µg.mL-1. The construct was 
introduce into CH12F3 cells by electroporation. 
II.1.3. SETX-Knockdown shRNAs and real-time quantitative PCR 






  We used the polyethylenimine (PEI) method for transfection. The shRNAs were 
mixed with the intended DNA/packaging vectors (psPAX2 and pMD2.G) at a ratio of 4:3:1 
(shRNA:psPAX2:pMD2.G) and PEI was added so as to have a DNA:PEI ratio of 3:4. Reduced 
serum medium Opti-MEM was added to the total at this point would be 1 mL. At the same time, 
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293 cells (passaged the night before so s to be ~75% confluent) are in 4 mL medium,  and the 1 
mL nucleotide-PEI-Opti-MEM mixture is added. The medium is changed once after 4-6 hrs, and 
a second time after overnight. The virus-containing supernatant is collected 48 hrs later. In a 1:1 
ratio, the virus-containing supernatant is added to a CH12F3 cells plated at 2 x105 cells.mL-1 and 
containing polybrene at 10-20 µg.mL-1, so the final polybrene concentration is 5-10 µg.mL-1. The 
cells can then be spun for 90 min at 1230 g at 30˚C. Finally, 75% of the supernatant can be 
removed and replaced with appropriate growth medium. After 48 hrs, the cells can be exposed to 
the selecting agent (in our case puromycin, at 0.5 µg.µL-1). 
II.1.4. SETX-Knockout in CH12F3 Cells 
 To knockout SETX in CH12F3 cells, we made use of the clustered regularly interspaced 
short palindromic repeats (CRISPR)-Cas9 technology (Ran et al., 2013b). We used the D10A 
RuvC/Cas9 nickase mutant, which can nick but will not cause a double-stranded break (DSB). A 
particular region of interest must therefore be targeted by two different nickases in order to 
induce DSB formation, with the beneficial effect of increasing DSB specificity over a system 
using wild-type Cas9 (Ran et al., 2013a, Ran et al., 2013b). We targeted mouse SETX and 
AICDA, the genes that encode the putative RNA/DNA helicase senataxin (SETX) and the B cell 
mutator enzyme activation-induced cytidine deaminase (AID). For each target, we devised two 
pairs of single guide RNA (sgRNA) sequences, which help the CRIPSR-Cas9 system recognize 
its target in DNA. 
SETX-targeted sgRNA pair 1: 5’-CTGCTACTGCTTAGAGTGTG-3' 
        and  5'-TGCTAGATGCATAGCGCTTT-3' 
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SETX-targeted sgRNA pair 2: 5'-AAGCGCTATGCATCTAGCAC-3' 
        and  5'-TCAATGGTGGAAGACCCACC-3' 
AICDA-targeted sgRNA pair 1: 5'-TGAGACCTACCTCTGCTACG-3' 
        and  5'-CATGCCGTCCCTTGGCCCAG-3' 
AICDA-targeted sgRNA pair 2: 5'-ACCTCTGCTACGTGGTGAAG-3' 
        and  5'-GTAGGTCTCATGCCGTCCCT-3' 
The SETX sgRNAs target exon 2, while exon 3 is targeted by the AICDA sgRNAs. 
II.1.5. SETX-Mutant Mouse 
 We obtained a mouse model to study SETX, wherein exon 4 has been deleted and 
replaced by a lox site (Becherel et al., 2013). To genotype we used the following primers: 
Forward Primer: 5′-TTTAAGGAACAGTGCTGC-3′  
Reverse Primer: 5′-ATGAAGCAGGTAGGATT-3′  
Reverse Primer lox: 5′-CGAAGTTATATTAAGGGT-3′ 
II.2. Methods 
II.2.1. EXOSC3 Allelic Deletion in Murine Cells 
 Mus Musculus animals 6-8 weeks in age were euthanized by CO2 inhalation as 
recommended by the 2000 Report of the American Veterinary Medical Association Panel on 
Euthanasia and approved by our university's Institution’s IACUC. In addition, cervical 
dislocation will be used as a secondary physical method of euthanasia. We then dissected out 
their spleens, dissociated the tissue using a syringe plunger as mortar and a cell strainer, and 
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isolated B lymphocytes by negative selection using CD43 beads Miltenyi Biotec. To allow for 
the inversion/deletion RNA exosome abrogation reaction to occur ROSACre-ERT2/+; EXOSC3COIN/
COIN ES cells, B lymphocytes, and their respective controls were exposed to 100 nM 4-
hydroxytamoxifen (from Sigma) in the appropriate cell culture conditions for 24 hours, after 
which the 4-OHT was washed away, and CSR medium was added for B cells, or regular tissue 
culture growth medium is added for ES cells. B cells must receive proliferation signal, lest they 
die; therefore during the inversion-deletion reaction, LPS is added to the growth medium at 20 
µg.mL-1. 
II.2.2. Bacterial Artificial Chromosome (BAC)-Fluorescence In-Situ Hybridization 
 The BAC-FISH assay starts when cells are harvested (after having been metaphase-
arrested by colcemid treatment, as in our case, or not). The metaphases are then fixed dropped on 
glass sides. At this point, labeled BAC-DNA containing the DNA sequence homologous to the 
target of hybridization can be added to the glass side. The DNA labeling is done with biotin or 
digoxigenin by nick translation: 1 µg of template BAC DNA and 4 µL of nick translation mix are 
briefly centrifuged and incubated at 15˚C; the reaction is then stopped by heating up to 85˚C and 
adding EDTA. Once the labeled BAC DNA probes are added to the glass side, denaturation from 
dsDNA to ssDNA is performed, as is the probe DNA-Genome DNA hybridization. Digoxigenin 
is then detectable by FITC-anti-dig fragment, and biotin by Cy5-streptavidin. We used two BAC-
DNA sequences flanking the IgH locus: BAC 207 (RP 22-207i23, coordinates are 12: 116023270 
- 116172952) is more telomeric, and slightly 5’ of the variable region of IgH, and BAC 199 
(CT7-199m11, coordinates 12: 113129176 - 113255643) is more centromeric and spans the 
Cα-3’RR region of IgH. 
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II.2.3. Cell Culture Conditions 
 All cells were incubated at 37°C in a 5% CO2 humidified incubator. Primary B cells were 
grown in Roswell Park Memorial Institute (RPMI) 1640 medium supplemented with 15% Fetal 
Bovine Serum (FBS) and 1X Non-Essential Amino Acids, 1mM Sodium Pyruvate, 10mM 2-[4-
(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid (HEPES), Penicillin-Streptomycin (100 
U.mL-1 Penicillin and 100 µg.mL-1 Streptomycin), 55 µM β-mercaptoethanol. CH12F3 and 
Ramos cells were grown in similar medium with the addition of 2mM L-glutamine. Human 
Embryonic Kidney 293 T cells were cultured in Dubelcco’s Modified Eagle Medium (DMEM) 
supplemented with 1X Non-Essential Amino Acids, 1mM Sodium Pyruvate, 10mM 2-[4-(2-
hydroxyethyl)piperazin-1-yl]ethanesulfonic acid (HEPES),  Penicillin-Streptomycin (100 U.mL-1 
Penicillin and 100 µg.mL-1 Streptomycin), 55 µM β-mercaptoethanol. ES cells were grown in 
Dubelcco’s Modified Eagle Medium (DMEM) supplemented with 15% Fetal Bovine Serum 
(FBS), 4mM L-glutamine, 1X Non-Essential Amino Acids, 1mM Sodium Pyruvate, Penicillin-
Streptomycin (100 U.mL-1 Penicillin and 100 µg.mL-1 Streptomycin), 110 µM β-
mercaptoethanol, and 120 µL ESGRO (Leukemia Inhibitory Factor, LIF). 
II.2.4. Class-Switch Recombination Assay 
 For primary B cells, CSR to IgG1 was initiated by adding 20 µg.mL-1 LPS and IL-4 (from 
R&D Systems) at 20 ng.mL-1 for 72 hrs (or 48 hrs if the inversion-deletion reaction was taking 
place in the presence of LPS for 24 hrs). For CH12F3 cells, CSR to IgA was initiated by adding 
20 µg.mL-1 LPS, 20 ng.mL-1 IL-4, and 1 ng.mL-1. After culture, cells were placed in 2.5% FBS in 
1X PBS, stained with the appropriate conjugated antibodies (FITC-conjugated anti- mouse IgA, 
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IgG1, CD19, anti-Rat IgG). We acquired data on a FACSAria cell sorter (BD Biosciences) and 
used FlowJo software for analysis. 
II.2.5. Immunoprecipitation and Immunoblotting Assay 
 Cells are lysed by douncing in buffer A (20 mM Tris, pH7.5, 1mM DTT, 10mM MgCl2) 
plus 10mM NaCl, 10% glycerol and protease inhibitors; an equal volume of buffer A + 1 M NaCl
+10% glycerol and protease inhibitors is added, followed by sonication and douncing. The 
extract is dialyzed against buffer A + 100 mM NaCl and centrifuged to remove debris. Cell 
lysates are pre-cleared with IgG-conjugated Pierce protein A/G agarose beads (Life 
Technologies) for at least 2 hours and then incubated with anti-human SETX antibody (Santa 
Cruz Biotechnology) plus protein A/G agarose beads for more than 6 hours, followed by several 
washes with cell lysis buffer plus 10% glycerol. The immunoprecipitated beads are boiled in 
protein loading buffer for SDS-PAGE. After the gel is run and the transfer to a PVDF membrane 
is completed, immunoblotting is performed with the appropriate antibodies. We used anti-RRP45 
(Novus), anti-AID, anti-human SETX (Santa Cruz). 
II.2.6. Electroporation of Cells 
 We used an Amaxa Nucleofactor II electroporator device from Lonza, and followed the 
manufacturer’s instructions. Depending on the plasmid size, 2-4 x 106 cells to be electroporated 
are suspended in an electroporation buffer solution (100 µL) containing the desired plasmid and 
placed in a cuvette in which the reaction will take place. After electroporation has occurred the 
solution 500 µL of 37 ˚C-medium are added to the cuvette, and the mixture is moved to 1 mL of 
growth medium pre-warmed to 37˚C. 
"71
II.2.7. Immunofluorescence Assay 
 Cells are placed on coverslips pre-treated with poly-L-lysine for 1 hr at room temperature 
and allowed to incubate for 60 min at room temperature or at 37˚C. The cells are then fixed using 
3-4% paraformaldehyde (PFA) at room temperature for 20 min. To quench autofluorescence, the 
coverslips are placed in 50 mM NH4Cl. They are then permeabilized with 0.1 % Triton X-100 for 
no longer than 1 min, before undergoing blocking (with 0.25% fish skin gelatin and 0.01% 
saponin in PBS) for 30 min. The appropriate primary antibody can then be used. In our case, we 
used the S9.6 anti-RNA:DNA hybrid antibody at 1:250 (Kerafast) (Boguslawski et al., 1986, 
Ginno et al., 2012). As secondary antibody, we used Alexa 488-conjugated Goat anti-Mouse at 
1:300 (Sigma). In another instance we used anti-γH2AX and anti-H2AX (Novus, Bethyl 
Laboratories) with their appropriate fluorophore-tagged secondary antibody. Images were 
captured with an EVOS digital inverted fluorescent microscope, and analyzed with the ImageJ 
software from the National Institutes of Health. For radiation-dependent experiments, cells were 
irradiated using an Atomic Energy of Canada Gammacell 40 Cesium irradiator at ~82 rad.min-1 = 
0.82 Gy.min-1 = 0.82 J.kg-1. 
II.2.8. RNA preparation and Real-Time quantitative PCR 
 Total RNA was isolated from cells using Trizol reagent (Life Technologies). RNA was 
resuspended in water and quantified using a Nanovue Plus spectrophotometer (GE Healthcare 
Life Sciences). RNA samples were treated with DNase I (Turbo DNA-free kit, Life 
Technologies), eluted in water and re-quantified. 1.5 µg of RNA were then converted to cDNA 
using random hexamers and the Superscript III First-Strand Synthesis System for RT–PCR (Life 
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Technologies).  We used two SETX primer pairs for real-time quantitative PCR reactions. These 
two pairs are: 
Primer Pair 1: Forward: 5’GTGGGTCTTCCACCATTGATG3’ 
  Reverse: 5’TGCTACTGCTTAGAGTGTGTGG3’ 
Primer Pair 2: Forward: 5’AAAATTAGCGCAGAGAAGTCTGG3’ 
  Reverse: 5’TCATTAAAGGATGGCTCTGTTGG3’ 
 We also used primers for the germline transcripts at switch sequences µ and α, GAPDH 
housekeeping control, and AICDA. 
For µ: 5′-CTCTGGCCCTGCTTATTGTTG-3′  
and 5′-GAAGACATTTGGGAAGGACTGACT-3′  
For α: 5′-CCTGGCTGTTCCCCTATGAA-3′  
and 5′-GAGCTGGTGGGAGTGTCAGTG-3′  
For GAPDH: 5′-TGGCCTTCCGTGTTCCTAC-3′  
and 5′-GAGTTGCTGTTGAAGTCGCA-3′ 
For AICDA: 5′-GGAACAGCAGAACTTCCAGACTTTG-3′ 
and 5′-CCTGAAAGTGAGCCTTAGAGGGAA-3′ 
Real-Time PCR was performed using the Light Cycler 480 II system by Roche Applied Science, 
using SYBR Green. Analysis was performed using the ∆-∆CT method.  
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II.2.9. Spectral Karyotyping 
 Spectral karyotyping assay was outsourced; a brief description of the steps follows. Cells 
on glass slides are treated with trypsin and dehydrated with ethanol washes. Their chromosomes 
are heat-denatured for no longer than 1.5 min and dehydrated again. Spectral karyotyping 
reagent aliquot is well mixed, denatured, and added to the denatured chromosome preparation; a 
cover slip is added for overnight incubation at 37˚C, removed the next day, washed, sequentially 
stained, and placed under coverglass. Spectral imaging software can then be used to analyze the 
data. 
II.2.10. Statistical Analysis 
 ANOVA and unpaired, two-tailed student t tests were used when possible. We used the 
software Prism for all statistical analysis calculations. Standard error of the mean was used 
whenever error bars are displayed. 
II.2.11. Telomere Fluorescence In-Situ Hybridization 
 Metaphase arrest is produced by cell exposure to N-desacetyl-N-methylocolchicine (also 
known as colcemid, at 200 ng.mL-1 for 2-4hrs). The cells are then spun and resuspended in 
prewarmed hypotonic solution (75 mM KCl) and incubated at 37˚C for 15 min. Fixative solution 
(3:1 methanol:glacial acetic acid) is added drop-wise. The mixture is spun and the pellet 
resuspended in fixative solution, and incubated at 4˚C for 15 min. The mixture is spun, the pellet 
resuspended in fixative solution, and allowed to incubate at 4˚C for 15 min once more. This is 
done a third time, after which the pellet, resuspended in fixative solution, can be dropped on 
glass slides that have been “hydrated” by being passed over water vapor emanating from a water 
at 80-90˚C (with side to be dropped on facing the vapor). Once the metaphases have been 
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dropped, the slide is passed over the water vapor again, on both sides, for 3-5 seconds at a time, 
then placed on a plate pre-heated to ~55-75 ˚C so as to dry the slide without burning the sample. 
Slow drying has tended to be better. The chromosomes can be fully visualized at this stage. The 
slides are left overnight, and the next day are washed with PBS, then fixed in 4% formaldehyde/
PBS, washed again in PBS, digested with acidified pepsin, washed and fixed again, and 
dehydrated with serial ethanol washes, before being allowed to air dry. The hybridization step 
follows and consists in adding the prepared fluorochrome-labelled telomeric peptide nucleic acid 
(PNA) probe to the slide and denaturing at 80˚C for 3 min. The probe mix contains 10 mM Tris 
at pH 7.2, buffer MgCl2, 70% deionized formatted, 0.25 % Boehringer Mannheim blocking 
regent, the hybridization probe (at 0.5 µg.mL-1) in water. After the denaturation step, the slide is 
allowed to incubate with the probe for 2 hours at room temperature in a humified chamber, at the 
conclusion of which formamide washes are performed (70% formamide, 10mM Tris, 0.1% BSA 
in water), followed by PBS/Tween washes, serial dehydration ethanol washes, and air drying. 
The slides are covered with Vectashield with DAPI mounting medium (from Vector 
Laboratories), and sealed with nail polish, before being stored in the dark. Images were captured 
with an EVOS digital inverted fluorescent microscope, and analyzed with the ImageJ software 
from the National Institutes of Health. Earliest T-FISH assays were conducted in collaboration 
with the Cancer Center. 
II.2.12. VPD450 Proliferation Assay 
 Washed cells are labelled by adding the prepared VPD450 dye from BD Bioscience to a 
concentration of 1 µM and allowing the cells to incubate in a 37˚C water bath for 10-15 minutes. 
The cells are then thoroughly washed and resuspended in appropriate growth medium, and can 
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be analyzed by flow cytometry. As with the CSR assay, we used FlowJo software to process our 
flow cytometry data. 
II.2.13. 5’ Sµ Sequencing 
 The 5’ subregion of Sµ was amplified by PCR with the following primers: 
 Forward: 5’-AATGGATACCTCAGTGGTTTTTAATG-3’ 
 Reverse: 5’-GCGGCCCGGCTCATTCCAGTTCATTA-3’  
 We used Turbo Pfu as follows: 28 cycles of 94°C (30 s), 58°C (30 s), and 72°C (40 s). 
The PCR products were then incubated with GoTaq DNA polymerase at 72°C for 10min and 
purified with a gel extraction kit (Qiagen) after electrophoresis in agarose gel. Purified PCR 
product was ligated with pGEM-T Easy vector and electroporated into XL-1 blue competent 
cells. White colonies were selected for minipreps and sequenced with T7 primer. Sequences were 
aligned with ClustalX. 
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Chapter III: Results 
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III.1. Genomic Instability Increase in RNA Exosome-Deficient B Cells 
III.1.1. CSR Defects in RNA Exosome-Deficient B cells  
 We wanted to investigate the extent to which impairing RNA exosome complex 
physiological function during the immunoglobulin R-loop reaction impacts B cell genomic 
integrity. The presence — and importance — of R loops to isotype switching by class-switch 
recombination (CSR) has increasingly been suspected and supported, culminating in the 
identification of the RNA exosome complex as an activity and targeting cofactor of AID 
deamination of deoxycytidine residues on both the looped-out non-transcribed DNA strand and 
the RNA-hidden template DNA strand at immunoglobulin switch sequence AID targets (Basu et 
al., 2011, Sun et al., 2013a, Pefanis et al., 2014, Pefanis et al., 2015). The interest in these 
RNA:DNA heteroduplex-containing R loop structures is augmented by the implication of 
RNA:DNA hybrids in pathophysiological processes, namely genomic instability (Wahba et al., 
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Figure 3.1. Effectiveness of inversion-deletion reaction. Exposure to 4-hydroxytamoxifen 
results in the nuclear translocation of the ubiquitously expressed recombined Cre-ERT2 protein 
where it can catalyze the inversion-deletion reaction of the EXOSC3COIN/COIN allele and the 
expression of a reporter GFP cassette. When both EXOSC3 alleles are wild-type, no GFP is 
detected by FACS (A). In the heterozygous background, GFP is detected in the vast majority of 
cells (B). In the homozygous  EXOSC3COIN/COIN background, close to 100% deletion is 
achieved. 
20140418 Workspace.jo Layout











































































































































































































































































































































































































































































































































































RosaCre-ERT2/+; Exosc3COIN/COINRosaCre-ERT2/+; Exosc3COIN/+RosaCre-ERT2/+; Exosc3WTA B C
2011). Transcription termination is hypothesized to be a required process at canonical AID 
targets for the desired, physiological immunoglobulin genomic alterations to take place before 
productive, full-length transcription of Ig loci (Storb, 2014). We set out to elucidate what the 
consequences of perturbing this process would be by abrogating RNA exosome activity, which 
had been described in the processing and/or degradation of many RNA species (Januszyk and 
Lima, 2014). 
 We utilized an inducible system to delete the gene EXOSC3 in mouse, which encodes 
RRP40, one of the nine core, essential subunits of the RNA exosome complex with a S1 and K-
homology RNA-binding domain (Pefanis et al., 2014, Pefanis et al., 2015). We reasoned that in 
the absence of appropriate levels of the different RNA exosome complex core components, the 
assembly of the 11 subunit RNA exosome complex would not proceed properly, and the activity 
of the complex would be abrogated. The deletion system employed allows the nuclear 
translocation, conditioned upon exposure to 4-hydroxy tamoxifen (4-OHT), of the constitutive 
and ubiquitous expression product of a Cre-ERT2 recombinase allele introduced at the ROSA26 
locus. In the nucleus, the recombined recombinase recognizes lox sites flanking the EXOSC3 
allele, and proceeds to delete it via an inversion-deletion reaction that results in the expression of 
a GFP cassette. First, to ensure that the expression of the GFP cassette in splenic B lymphocytes 
exposed to 4-OHT for 24 hrs (along with lipopolysaccharide, LPS, to prevent cell death) 
proceeded as planned, we analyzed these cells by fluorescence-activated cell sorting (FACS, 
Figure 3.1). We use the detection of GFP by FACS as a substitute for successful EXOSC3 allelic 
inversion-deletion. We observe that ROSA26Cre-ERT2/+; EXOSC3WT cells do not have detectable 
levels of GFP, while the ROSA26Cre-ERT2/+; EXOSC3COIN/+ and the ROSA26Cre-ERT2/+; 
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EXOSC3COIN/COIN do, with the ROSA26Cre-ERT2/+; EXOSC3COIN/COIN cells having levels that are 
slightly higher. The high detection levels of GFP in both EXOSC3COIN/+ and EXOSC3COIN/COIN 
backgrounds indicate that the inversion-deletion reaction proceeded with success. 
 As previously reported, we observed that the ability of isolated RNA exosome-deficient 
splenic B lymphocytes to engage in isotype switching from IgM to IgG1 is severely impaired in 
contrast to RNA exosome-sufficient ROSA26Cre-ERT2/+; EXOSC3COIN/+ cells, indicating that the Ig 
R loop reaction may be negatively impacted by RNA exosome functional abrogation (Figure 3.2)
(Basu et al., 2011, Pefanis et al., 2014). However, a fraction of B lymphocytes thought to have 
abrogated RNA exosomse activity can still remodel their Ig loci to produce the IgG1 isotype 
(Figure 3.2).   
III.1.2. Structural Catastrophic Events in Stimulated RNA Exosome-Deficient B cells  
 We then set out to find out whether the abrogation of RNA exosome function affected the 
genomic integrity of the B cells lacking the complex. Numerous accounts have suggested that the 
accumulation of RNA:DNA species is detrimental to cellular health by generating genomic 
instability (Huertas and Aguilera, 2003, Tuduri et al., 2009, Wahba et al., 2011). These 
RNA:DNA species may accumulate as a result of deficient RNA processing mechanisms that 
increase the relative amounts of RNA available for base-pairing with negatively supercoiled 
DNA, either through co-transcriptional defects that may result in increased RNA:DNA hybrids 
formed in cis, or through post-transcriptional defects that may result in increased RNA:DNA 
hybrids formed perhaps in trans at a different DNA locus sharing some homologue (Kim and 
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Jinks-Robertson, 2012, Wahba et al., 2013, Costantino and Koshland, 2015). Given the 
implication in yeast of catalytic RNA exosome subunit Rrp6 in the genesis of genomic 
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Figure 3.2. CSR in exosome-deficient mouse B cells. Ex vivo 4-OHT-exposed RNA exosome-
deficient B lymphocytes exhibit a defect in their ability to complete isotype switching to IgG1 
upon stimulation with IL-4 and LPS. A. ROSA26Cre-ERT2/+; EXOSC3COIN/COIN cells have high 
levels of GFP and low levels of IgG1, while a substantial portion of cells wild-type for EXOSC3 
are IgG1+. B. Relative RNA Exosome-competent backgrounds, RNA Exosome-deficient cells 




mouse B cells by performing a telomeric fluorescence in situ hybridization (T-FISH) assay on 
them (Wahba et al., 2011).  
 We thought that a T-FISH assay would allow us to detect general structural abnormalities 
in chromosomal integrity in the absence of the key RNA processing machinery RNA exosome. 
We isolated splenic B lymphocytes from mice with different susceptibilities to the CreERT2-
mediated inversion-deletion reaction, exposed them to 4-OHT, induced them to undergo IgM-to-
IgG1 class-switch recombination by stimulating them with an LPS-interleukin 4 (IL-4) cocktail 
for 3 days, and caused them to metaphase-arrest by providing them with colcemid (a less toxic 
relative of the microtubule-disruptive compound colchicine) that prevents metaphase-to-
anaphase passage (Rieder and Palazzo, 1992). We then performed a number of washes and fixed 
the cells, before “dropping” these metaphase preparations on glass slides, where a fluorophore-
tagged telomeric probe was allowed to hybridize to the genomic material. When compared to 
RNA exosome-sufficient backgrounds, ex vivo CSR-activated RNA exosome-deficient B 
lymphocytes displayed a marked increase in the proportion of metaphases containing genomic 
instability. We noticed a number of changes, including the loss of telomeres (both at centromeric 
and telomeric chromosomal ends), the presence of acentric fragments (which simply denotes the 
absence of a centromere in this DNA specimen), the fusion of two chromosomes into one 
dicentric chromosome, the end-to-end fusion of sister chromatids intra-chromosomally, and, 
rarely, the formation of so-called radials (Figures 3.3A and 3.3B). Radials are chromatid-type 
errors thought to occur at DNA polymerase stalling sites, where a chromatid break is repaired by 
the insertion of another chromosome (which also bears a chromatid break in the case of 
quadriradials) (Savage, 1976, Scully et al., 2000, Satoh et al., 2002). For all subtypes of genomic 
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Figure 3.3A. Structural abnormalities in RNA exosome-deficient stimulated B cells. Examples 
are shown of telomeric telomere loss, acentric chromosomal fragments, and dicentric 
chromosomes. These abnormal chromosomal structures accrue at a higher degree in activated 
ROSA26Cre-ERT2/+; EXOSC3COIN/COIN B lymphocytes than in other their RNA exosome-
competent counterparts. Structures are shown with fluorophore and 4’,6-diamidino-2-
phenylindole (DAPI) staining (on the left) and with transmitted light (on the right). Densities 
are indicative of centromeres. Chromosomal fragments without centromeres are acentric 
(middle row), while chromosomal structures with 2 centromeres are dicentric (bottom row). 
Fluorophore-labeled telomeric probes denote the presence or absence of telomeres (centromeric 
or telomeric telomeres; seen here is telomeric telomere loss in the top row).






Figure 3.3B. Structural abnormalities in RNA exosome-deficient Stimulated B Cells. 
Additional representations are shown for homologous end-to-end fusion, radial, and long 
acentric chromosomes. These abnormal chromosomal structures also accrue at a higher degree 
in activated ROSA26Cre-ERT2/+; EXOSC3COIN/COIN B lymphocytes than in other their RNA 
exosome-competent counterparts. Note the chromatid fusion and absence of telomeric 
telomeres in the top picture pair; the middle pair shows a quadriradial chromosome; the bottom 
pair shows a long acentric chromosome: while in 2 mouse chromosomes, lack of a centromere 
is expected, this chromosome is excessively long to be one of those.
metaphases with telomeric loss (whether telomeric telomeres or centromeric telomeres) and from 
metaphases with acentric chromosomes, vastly account for the difference observed in the 
proportions of metaphases with instability between RNA exosome-deficient and RNA exosome-
sufficient backgrounds (Figure 3.4). 
 The increase in catastrophic events in the absence of physiological RNA exosome activity 
was striking. Still, we thought that our assay restricted our analysis only to those genomic 
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Figure 3.4. Breakdown of chromosomal instability events. A compilation of the different 
phenotypes is plotted in this bar graph for the three backgrounds. For all abnormalities, we 
observed a statistically significant difference between the RNA exosome-deficient B cells and 
the RNA exosome-competent backgrounds: ANOVA, p = 0.0409, R2 = 0.5989. 4 animals were 
used for the WT background, 2 for the heterozygous background, and 4 for the ROSA26Cre-
ERT2/+; EXOSC3COIN/COIN background. The respective number of metaphases analyzed is 
indicated for each mouse background.
instability instances that resulted in chromosomal structural changes perceptible by T-FISH, 
namely, improperly repaired chromosomal breaks, dicentric or acentric chromosomes, and intra-
chromosomal chromatid end-to-end fusion events. Were a break to occur and be successfully 
repaired, our assay could not enable us to recognize such an accidental occurrence; similarly, 
were a balanced, pathophysiological translocation event to take place, our T-FISH assay would 
not be able to reveal that disease-predisposing genetic material rearrangement. We would not 
able to detect any changes that may have occurred more proximal to the presumably RNA 
exosome absence-related insult, which may have been repaired by the a priori intact cellular 
repair mechanism. We therefore set out to increase the stress encountered by these B cells by 
exposing them to ionizing radiation and assaying for instability. 
III.1.3. Genomic Instability in IR-Exposed Stimulated RNA Exosome-Deficient B cells  
 As we did before, we isolated splenic B lymphocytes and grew them ex vivo in the 
presence of LPS and 4-OHT for the first 24 hours to abrogate RNA exosome activity, followed 
by an LPS and IL-4 treatment for an added 48 hours to allow for CSR to occur. We then 
irradiated the cells for different periods: 0 min, 2.5 min, and 24.5 min, meaning that the cells 
were correspondingly exposed to 0 Gy, 2 Gy, and 20 Gy of irradiation. We had initially set out to 
perform a T-FISH assay on these cells; but multiple attempts yielded no usable metaphase 
spreads, perhaps because the exposure to colcemid in addition to irradiation proved excessively 
toxic for the cells. In parallel, we had wanted to perform an immunofluorescence (IF) assay on 
these cells using antibodies that recognize proteins involved in the repair of double-stranded 
DNA breaks. To do this, we first allowed irradiated cells to recover for 45 min, after which we 
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washed, fixed, and prepared them for IF. We settled on 45 min because after longer recovery 
periods (5.5 hrs and 10.5 hrs), assayed DSB repair proteins were mostly no longer detectable by 
IF, and shorter recovery periods were not logistically consistently achievable, given the number 
of assay steps and samples involved. We performed IF using antibodies against γH2AX, the 
phosphorylated form of the histone variant protein H2A and analyzed the data using the software 
ImageJ. It is thought that upon sensing of double-stranded DNA breaks by the complex formed 
by MRE11 (meiotic recombination homolog 11), RAD50 (radiation sensitive mutant 50), and 
NBS1 (Nijmegen-breakage syndrome 1), phosphatidylinositol-3-kinase-like family of protein 
kinases (which include DNA-dependent protein kinase catalytic subunit (DNA-PKcs), Ataxia 
telangiectasia mutated (ATM), and ATM- and RAD3-related (ATR)) will be activated and in turn 
will phosphorylate H2AX at its serine 139 residue to produce γH2AX, which will induce the 
recruitment of additional DNA repair proteins (Kinner et al., 2008). The aggregation of these 
phosphorylated γH2AX proteins into foci at or near sites initially recognized by the cell can 
therefore be used as a biomarker proxy for the presence of a double-stranded DNA break (Kuo 
and Yang, 2008). 
 We observe that at 0 Gy, stimulated B cells, RNA exosome-sufficient and -deficient alike, 
have minimal amounts of γH2AX (Figure 3.5). It is not all too surprising that there should be 
some amount of γH2AX detection, reflecting the DSBs that are bound to be formed in 
proliferating cells in general, and stimulated B cells in particular, since DSBs are an intermediate 
for class-switch recombination. When we evaluate the percentage of stimulated, irradiated, fixed 
cells that accumulate 3 or more γH2AX foci, we see that at baseline 0 Gy levels very few to no 
RNA exosome-sufficient B cells accumulate these foci, and that B cells with compromised RNA 
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exosome activity already exhibit a statistically significant difference (by ANOVA), small though 
it be (Figure 3.5). Exposing the ex vivo activated B lymphocytes to 2 Gy does not seem to 
drastically change the observations made at baseline (Figure 3.6). The RNA exosome-sufficient 
ROSA26Cre-ERT2/+; EXOSC3WT and ROSA26Cre-ERT2/+; EXOSC3COIN/+ backgrounds display around 
the same amount of γH2AX as detected at 0 Gy in our assay, which is again lower, in a 
statistically significant manner, than the amount of γH2AX detected in the ROSA26Cre-ERT2/+; 
EXOSC3COIN/COIN background. Similarly, when we examine the percentage of activated, 2 Gy-
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Figure 3.5. γH2AX immunofluorescence assay of 0-Gy irradiated stimulated B cells of different 
backgrounds. A. IF Images of cells with different backgrounds. B. Low levels of γH2AX are 
detected by integrated density, though a small, significant difference is apparent among RNA 
exosome-non-deficient and RNA exosome-deficient backgrounds by ANOVA. By unpaired, two-
tailed Student’s t-test, p = 0.0561 for WT and C/C, 0.07916 for C/+ and C/C, and 0.738228 for WT 
and C/+. C. Very few cells accumulate 3 or more γH2AX as detected in our assay. RNA exosome-
deficient cells show a statistically significant increase nonetheless.  





























































irradiated, fixed cells that accumulate 3 or more γH2AX foci, RNA exosome-sufficient B cells 
tend to not accumulate these foci, whereas RNA exosome-deficient B cells exhibit a statistically 
significant increase, comparable to the baseline difference (Figure 3.6). It appeared that the 
increase in IR stress did not translate into a higher preponderance of DSBs as measured by 
γH2AX foci accumulation in our assay.  
 We then increased the IR stress by exposing the stimulated B cells to 20 Gy, a tenfold 


























































γH2AX IF 45 min after 
2 Gy Irradiation
Figure 3.6. γH2AX immunofluorescence assay of 2-Gy irradiated stimulated B cells of different 
backgrounds. A. IF Images of cells with different backgrounds now start to show γH2AX in the 
RNA exosome-deficient background. B. The difference between RNA exosome-deprived and RNA 
exosome-containing backgrounds is slightly more pronounced than at 0 Gy, though still relatively 
small. Still, a statistically significant difference is perceptible among the different backgrounds. By 
unpaired, two-tailed Student’s t-test, p = 0.0339 for WT and C/C, 0.0159 for C/+ and C/C, and 
0.0954 for WT and C/+. C. Cells with 3 γH2AX or more are more frequent in the RNA exosome-
deficient primary B cell background. 
A B
C
backgrounds with intact RNA exosome function and B cells with abrogated RNA exosome 
activity experienced an increase in the amounts of γH2AX detected in our IF assay. Overall 
γH2AX detection levels increased in all three backgrounds compared to the previous IR 
exposures, with the RNA exosome-sufficient cells seeing a ~ twofold increase in γH2AX, while 
RNA exosome-deficient cells had around triple the levels of γH2AX (Figure 3.7). But analyzing 


























































γH2AX IF 45 min after 
20 Gy Irradiation
Figure 3.7. γH2AX immunofluorescence assay of 20-Gy irradiated stimulated B cells of different 
backgrounds. A. IF Images of cells w th different backgrounds show massive γH2AX foci 
accumulation in the RNA exosome-deficient background. B. As IR stress increases to 20 Gy, 
γH2AX is also detected in cells with proper RNA exosome activity, though at lower levels than in 
RNA exosome-deficient background. By unpaired, two-tailed Student’s t-test, p = 0.0014 for WT 
and C/C, 0.0013 for C/+ and C/C, and 0.3419 for WT and C/+. C. All cell backgrounds exhibit at 
least a small percentage of cells with 3 or more γH2AX foci subsequent to irradiation, though that 
percentage is much larger in the RNA exosome-deficient primary B cells.
A B
C
deficient background was drastically larger, at about tenfold (Figure 3.7). A small but non-
negligible portion of RNA exosome-sufficient backgrounds also displayed an accumulation of 
γH2AX foci, though much less than the percentage seen in the deficient background. The 
differences observed at 20 Gy were again statistically significant (Figure 3.7). We ensured that 
the changes in γH2AX were not due to higher levels of non-phosphorylated H2AX protein in the 
cells by performing the same IF assay on the various RNA exosome backgrounds using an anti-
H2AX antibody after irradiating the cells at 20 Gy (Figure 3.8). We see no statistically 
significant difference among the three RNA exosome backgrounds, indicating that the changes 























H2AX IF 45 min after 
20 Gy Irradiation
Figure 3.8. Non-phosphorylated H2AX immunofluorescence assay of 20-Gy irradiated stimulated 
B cells of different backgrounds. IF images of CH12F3 cells with different backgrounds show non-
phosphorylated H2AX is readily detected in all three backgrounds (A), and no statistically 
significant difference among the backgrounds is noted (B) by ANOVA and by unpaired, two-tailed 
Student’s t-test (p = 0.1367 for WT and C/C, 0.1497 for C/+ and C/C, and 0.7888 for WT and C/+) 
A
B
comparison among levels of detected γH2AX in the different backgrounds, the various 
measurements were re-plotted on the same graphs (Figure 3.9). 
III.1.4. Identity Clues in Chromosome SKY 
 The T-FISH and IR/IF assays gave us some appreciation of the magnitude of compromise 
in chromosomal structural integrity that results from the absence of physiological levels of RNA 
exosome complex in stimulated B lymphocytes. We had wanted to identify the loci involved in 
these catastrophic events. We set out to perform Giemsa-banding (G-banding), which we thought 
would provide valuable resolution information in the identification of loci involved in genomic 
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Figure 3.9. Compilation of immunofluorescence/irradiation data. The different RNA exosome 
backgrounds are plotted for γH2AX accumulation after ionizing radiation at different levels. A. 
The leftmost plot represents the detected γH2AX intensity in integrated density arbitrary units. B. 
The rightmost plot shows the percentage of analyzed fixed cells with 3 γH2AX foci or more. 
Irrespective of the amount of IR, RNA exosome-deficient backgrounds accumulate more double-
stranded breaks as assayed by γH2AX IF; at 20 Gy, in conditions of high mutagenic stress, RNA 
exosome-deficient cells show a dramatic increase in γH2AX accumulation, suggesting they are 
more sensitive to increases in mutagenic stress.
BA
instability events (Sumner et al., 1971). Ultimately, we opted for a different approach. We 
thought to perform spectral karyotyping of RNA exosome-deficient activated B cells. Spectral 
karyotyping (SKY) a ca. 20-year old multicolor FISH-based technology that allows for the 
hybridization-mediated simultaneous discernment of the different chromosomes and their 
painting in different colors (Schrock et al., 1996). We obtained SKY results in a CSR-stimulated, 
RNA exosome-deficient ROSA26Cre-ERT2/+; EXOSC3COIN/COIN background, compiled in Figure 
3.10. What is immediately noticeable is one translocation event involving murine IGH-locus 
bearing chromosome 12. The involvement of chromosome 12 is additional evidence that RNA 
exosome-mediated instability is possibly partly related to the biology of R loop resolution, 
notably at Ig loci. We observed that the translocation event resulted in the formation of a 
dicentric chromosome, with acentric chromosome 12 byproducts also detectable. These 
observations are reminiscent of some of the results we obtained in our T-FISH screen. 
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Figure 3.10. Spectral karyotyping. Stimulated RNA exosome-deficient B lymphocytes were 
metaphase arrested and prepared for spectral karyotyping. Each chromosome is painted in a 
unique color, allowing for easy chromosomal identification. Of note here is the translocation 
event involving chromosome 12 and resulting in a dicentric chromosome formed with 
chromosome 1. Also visible is the fragmentation of chromosome 17.
Interestingly, we noticed that the other chromosome involved in the translocation transaction is 
chromosome 1, which in mouse bears two genes (BCL2 and PTPRC) associated, respectively, 
with B-cell cancers or B-cell cancers, severe combined immunodeficiency (SCID), and multiple 
sclerosis (Strasser et al., 1990, Tchilian et al., 2001, Wu et al., 2002, Carulli et al., 2008, Basso 
and Dalla-Favera, 2015). Another noteworthy observation is the genomic instability event 
occurring on chromosome 17, which in mouse is where the AID-mutated proto-oncogene PIM1 
is found, and where we reported finding RNA:DNA hybrid accumulation in the absence of 
proper RNA exosome activity (Hilkens et al., 1986, Pasqualucci et al., 2001, Pasqualucci et al., 
2004, Pefanis et al., 2014). Additional SKY-assayed metaphase-arrested stimulated RNA 
exosome-deficient B cells ought to be examined before we are able to make conclusive remarks. 
Still, our results give us clues as to which genomic loci might be involved during the genomic 
instability events and might be implicated in the pathophysiology of a given B-cell 
immunoproliferative or an immunodeficiency disorder. 
  
III.1.5. RNA exosome Deficiency-Related Instability in ES Cells  
 Subsequently, we undertook the question of the AID- and/or class-switch recombination 
(CSR)-relatedness of these observations. AID is a powerful mutagen, whose activity is highly 
regulated and mostly channeled towards physiological mutagenesis-initiated immunoglobulin 
locus remodeling in activated B cells, though it is also sometimes associated with a number of 
disorders, as was discussed previously. We wanted to find out whether the genomic instability 
phenotype seen after abrogation of RNA exosome physiological activity was associated to AID 
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and/or CSR. We hypothesized that to the extent that R loops may be conducive to instability, at 
least some of this instability would indeed be associated to AID-activity in the context of a B 
lymphocyte undergoing CSR, while some may be unrelated to AID mutagenic activity or to the 
double-stranded break intermediates generated during CSR, and may instead reflect other 
dynamic transcription-associated mutagenesis (TAM) and recombination (TAR) events, 
particularly in light of the recent description of early replicating fragile sites, some of which 
seem to be AID-independent while other seem associated to AID (Kim and Jinks-Robertson, 
2012, Barlow et al., 2013).  
 To explore this question, we performed the T-FISH assay on embryonic stem (ES) cells 
from mice with the ROSA26Cre-ERT2/+; EXOSC3COIN/COIN background. ES cells provide a 
convenient tool in which to study the effects of RNA exosome activity abrogation in a high 
proliferation system where neither the B lymphocyte-specific somatic hypermutation nor class-
switch recombination are occurring. Before exposure to 4-OHT, cells bearing the re-engineered 
EXOSC3 conditional locus express normal levels of RRP40, which then go down once exposure 
to tamoxifen has taken place (Pefanis et al., 2014). We assayed the cells before exposing them to 
4-OHT as well as after 4-OHT exposure. As with B cells lacking proper RNA exosome activity, 
we observed that compared to pre-abrogation ES cell metaphases, more RNA exosome-deficient 
ES fixed metaphases displayed structural chromosomal abnormalities (Figure 3.11). We then 
wanted to compare the instability observed in the ES-cell and B-cell backgrounds. To do this, we 
calculated a “genomic instability index,” which gives us an estimation of the instability in RNA 
exosome-deficient cells relative to their RNA exosome-sufficient counterparts in both the ES-cell 
and B-cell backgrounds (Figure 3.11). We calculated that the genomic instability index derived 
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from RNA exosome-deficient B cells is 62% higher than the genomic instability derived from 
RNA exosome-deficient ES cells (4.331 vs 2.672, respectively), suggesting that the genomic 
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Telomere Loss Dicentric Chromosome Acentric
Chromosomal 
Fusion
Figure 3.11. Embryonic stem cell T-FISH. ROSA26Cre-ERT2/+; EXOSC3COIN/COIN ES Cells were 
subjected to a T-FISH assay before exposure to 4-OHT (therefore before RNA exosome 
function-abrogation) as well as after exposure to 4-OHT (when RNA exosome assembly is 
impaired). A. The images showcase examples of different structural abnormalities akin to those 
seen in stimulated B lymphocytes lacking proper RNA exosome function. B. The left plot 
compares the percentage of fixed metaphase with chromosomal abnormalities before and after 
RNA exosome abrogation. C. The right plot shows the genomic instability indices devised to 
compare the level of genomic instability observed when RNA exosome activity is impaired in 
both ESCs and B cells. 
A
B C
instability burden in activated, RNA exosome-deficient B cells is higher than in proliferating 
RNA exosome-deficient ES cells, even when normalized to their respective baseline genomic 
instability levels. These results provide some indication that part of the genomic instability seen 
in B cells may be non-related to AID activity, while a portion of this instability may in part be 
due to the genomic alterations that are specific to these cells. 
III.1.6. Ubiquitination Dynamics In the Ig R-loop Reaction   
 There is evidence that RNA polymerase II gets monoubiquitinated by the E3 ligase 
NEDD4, which can instigate pol II polyubiquitination by another enzyme and precipitate its 
destabilization from loci where it had stalled, providing access to the template DNA strand to the 
single-stranded mutator AID to initiate physiological genomic alterations (Anindya et al., 2007, 
Harreman et al., 2009, Rotin and Kumar, 2009, Cheung and Cramer, 2012, Sun et al., 2013a). 
NEDD4 would therefore be involved in the putatively stabilizing monoubiquitination of RNA 
polymerase II and the degradation-mediating polyubiquitination of RNA polymerase II. Different 
cellular outcomes are possible for each of these NEDD4 roles, and the interactions among the 
different post-translational modification pathways are still not entirely elucidated. 
 We isolated splenic B cells from wild-type mice and grew them ex vivo with the CSR-
inducing LPS and IL-4, along with the E1 heterodimer component protein APPBP1/NAE 
inhibitor MLN4924, a small molecule structurally related to 5’-monophosphate (AMP), which is 
produced in the ATP-dependent E1 reaction (Soucy et al., 2009). We wanted to see what the 
effect of impairing this pathway would be on the genomic integrity of activated B cells. Prior 
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work in our laboratory had shown that NEDD4 supports CSR and promotes AID interaction with 
its cofactors in the Ig R loop reaction, Spt5 and RNA exosome (Sun et al., 2013a). The NAE 
inhibitor MLN4924 was used at different concentrations (0 mol.L-1, 62.5 nmol.L-1, and 125 
nmol.L-1) for 72 hours, along with the CSR cocktail, after which colcemid was added to induce 
metaphase arrest. A series of washes followed to fix the metaphases and perform a T-FISH assay. 
Although MLN4924-non-treated cells were able to yield metaphases, only few metaphases were 
obtainable with the drug-treated B lymphocytes, preventing us from performing a proper 
analysis. It seems that the drug had some toxic effects, as almost no usable metaphase spreads 
were obtained from the 125 nmol.L-1 treatment (Data not shown) (Whitby et al., 1998, Hjerpe et 
al., 2012, Enchev et al., 2015). We then attempted to investigate NEDD4 involvement in the Ig R 
loop reaction-mediated genomic instability differently by using B cells from mouse fetal liver 
chimeras expressing a C-terminally deleted form of NEDD4, i.e., mutants that no longer have an 
intact ubiquitin ligase-containing HECT domain (Yang et al., 2008). Impairing NEDD4 could in 
theory affect not only AID neddylation, but RNA polymerase II mono/polyubiquitination as well. 
We set out to find out if perturbing NEDD4 levels would have a consequence on genomic 
instability. We isolated splenic B cells from these chimeric mice, grew them ex vivo in medium 
contain LPS and IL-4 for 3 days, arrested them at metaphase by colcemid exposure, and 
completed the T-FISH assay by fixing and hybridizing the genomic material; control B cells were 
from fetal chimeric mice expressing non-truncated NEDD4 (Sun et al., 2013a). Unlike with the 
MLN drug treatment T-FISH assay, metaphases were readily obtainable in the absence of 
physiological NEDD4 from fetal liver chimeric mouse B cells. We noticed that there was no 




















Figure 3.12. NEDD4-/- T-FISH. CSR-stimulated 
B cells from mouse fetal liver chimeras that 
have either wild-type or abrogated NEDD4 
activity are prepared and assayed for T-FISH, 
and images from these assays are shown in A. 
In B, a plot with instability levels of both 
NEDD4-/- and  NEDD4+/+ backgrounds shows 




III.2. Senataxin in the Ig R-loop Reaction 
III.2.1. SETX Associates with AID and RNA Exosome  
 In our quest to decipher the intricacies behind the immunoglobulin R-loop reaction that 
permit the access of the mutator enzyme AID to both the readily accessible non-transcribed DNA 
strand and the RNA-hidden DNA strand of its target sequences during transcription, we 
identified the RNA exosome complex as a critical cofactor or AID activity and targeting (Basu et 
al., 2011, Pefanis et al., 2014). We also contemplated the possibility that other players might be 
involved in the Ig R-loop reaction. Previous work in Saccharomyces cerevisiae had shown that a 
complex formed by Sen1 (the yeast orthologue of SETX) with Nrd1 (N-arginine dibasic 
convertase) and Nab3 (nuclear polyadenylated RNA-binding protein 3) physically interacts 
through Nrd1 with the RNA exosome complex to mediate transcription termination (Vasiljeva 
and Buratowski, 2006). More recently, a report using a yeast two-hybrid screen, with as prey a 
human brain cDNA library and as bait the amino terminal region of SETX, suggested a SUMO-
dependent interaction between the RNA Exosome subunit RRP45 and SETX (Richard et al., 
2013). The RNA exosome is composed of a hetero-nonameric core that can interact with 
catalytic cofactors to bring about its 3’→5’ exo- or endoribonuclease activities to degrade or 
process various RNA classes, and RRP45 is a core-component subunit of the RNA exosome 
complex (Januszyk and Lima, 2014). By analogy to the involvement of its orthologue in 
transcription termination at G-rich sequences downstream of polyA sites, we thought that SETX 
could, too, be involved in transcription termination during the Ig R-loop reaction. In order to 
investigate the potential involvement of SETX in antibody diversification mechanisms, we 
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therefore set out to find out whether SETX interacts with AID, the initiator and bona fide protein 
of antibody diversification reactions, and the RNA exosome complex in a B-cell background. 
 Because of the dearth of usable antibodies against murine SETX, we performed 
immunoprecipitation (IP) assays on Ramos cells, a human Burkitt’s lymphoma cell line (Klein et 
al., 1975). We prepared Ramos cell lysates, washed them, incubated them with antibody-coupled 
agarose A/G protein, and eluted protein complexes before sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblot assaying with the appropriate 
antibodies. We observe that, similar to corroborating evidence in previous but different organism 
backgrounds, SETX interacts with RRP45 in Ramos cells (Figure 3.13). Furthermore, we 
observed that SETX also interacts with AID (Figure 3.13). Taken together, these results place the 
helicase SETX at the very center of the immunoglobulin R-loop reaction and strongly indicate 














Figure 3.13. SETX immunoprecipitation. Human 
Burkitt’s lymphoma Ramos cells were harvested, 
lysed, and prepared for SETX immunoprecipitation. 
Whole cell lysate and IgG controls are displayed., 
along with Western blotting using antibodies against 
AID and RNA exosome core subunit RRP45.
III.2.2. SETX-deficient CH12 Cells Exhibit Impaired CSR 
 We next set out to determine if, in fact, SETX occupies such a role in class-switch 
recombination. We reasoned that if SETX plays an important role during CSR, defects in 
switching ability should be perceptible when SETX activity is impaired. We proceeded to 
knockdown the expression of the SETX gene using the CH12F3 cell line, a murine B-cell 
lymphoma cell line that is able to undergo isotype switching upon stimulation (Arnold et al., 
1983, Kunimoto et al., 1988, Nakamura et al., 1996). We introduced lentiviral backbone and 
shRNA-containing plasmids into 293T cells to produce packaged virus for the spinfection  of our 
CH12F3 cells to cause the down regulation of SETX. Our knockdown approach, evaluated by 
RT-PCR using sets of primers that recognize two distinct regions of the gene, resulted in a 
statistically significant decrease of about 40 to 60 percentage points in SETX mRNA levels 
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Figure 3.14. SETX Transcription 
levels in knockdown background. 
quantitative PCR was performed on 
murine CH12F3 cells containing a 
control vector or a senataxin 
knockdown construct. Displayed 
here are results of an analysis using 
two primer sets. Results are shown 
relative to control vector levels. 
Student t test was used in either case, 
and primer pair 1 had p = 0.0061, 
while for primer pair 2, p = 0.0003  
(Figure 3.14). Because CH12F3 cells are of murine background, we were not able to assay and 
compare SETX protein levels in the different knockdown conditions.  
 Transcription plays a crucial role for proper, AID-initiated physiological CSR (Ramiro et 
al., 2003). To evaluate whether germline transcription decreased as a result of knocking down 
SETX, we monitored µ and α switch sequence transcription in the SETX knockdown 
background. We observed that germline transcription at switch sequences was not adversely 
impacted under these conditions (Figure 3.15). AID is the critical mutagen that initiates both 
SHM and CSR (Muramatsu et al., 2000). Given this critical role in Ig diversification, we also 
checked the mRNA levels of AICDA in the SETX knockdown background. As we had before, we 
observed that the knockdown conditions did not seem to negatively impact AID mRNA levels 
(Figure 3.15).  
 To further minimize confounding factors, we appraised the proliferation proficiency of 
the CH12F3 cells in our experiment, hoping to get a sense of their general viability in conditions 
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Figure 3.15. Transcription at IGH switch sequences and AICDA in K/D 
Background. Sµ and Sα germ line transcripts (GLT) in shSETX knockdown 
backgrounds are shown, as is the transcription at mouse AICDA, relative to 
control background. We observed no statistically appreciable defect in 
transcription at any of the three loci.
of SETX knockdown. For this, we used the violet laser excitable Violet Proliferation Dye 450 
(VPD 450), which passively diffuses into cells and is cleaved by esterase activity within viable 
cells to become fluorescent; upon dividing, these cells partition their dye into similar amounts 
between the next-generation cells, causing a dilution in the overall dye intensity. We measured 
VPD450 at 24-hour intervals over 72 hours. We observed that there was no proliferation 
deficiency and that the knockdown and control backgrounds behaved similarly (Figure 3.16).  
 Next, we stimulated the cells to undergo isotype switching to IgA. We exposed CH12F3 
cells with different backgrounds to LPS, IL-4, and transforming growth factor β (TGF-β) for 48 
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Figure 3.16. Proliferation of SETX knockdown CH12F3 cells. Using the dilution dye VPD450, 
we tracked the proliferation of  CH12F3 cells containing control vector or shSETX knockdown 
construct over 3 days. As the cells proliferate, the intensity of the dye decreases. Shown in blue 
are cells that were not stained, while in red are stained cells. As the cells proliferate, the 
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Figure 3.17 Class-switch recombination of SETX-deficient CH12F3 cells. A. FACS plots show 
on the top row staining controls, and on the bottom row experimental results, with control 
vector CH12F3 cells, SETX-deficient cells, and AID-deficient cells. Stimulated CH12F3 cells 
deficient in SETX show CSR results that are comparable to the AID control. B. After multiple 
repeats of the isotype switching assay, the comparative plot was drawn. There is a statistically 
signifi ant decrease from th  control vector backgro nd to the SETX-deficient background 
(unpaired student t test, p = 0.0002), as well as between the SETX-deficient and the AID-
deficient backgrounds (unpaired student t test, p = 0.0182).
A
B
CH12F3 cells resulted in a substantial reduction in their ability to undergo CSR, as measured by 
the proportion of SETX-deficient CH12F3 cells expressing IgA on their surface (Figure 3.17). In 
this regard, CSR in SETX-deficient CH12F3 cells greatly resembled CSR in AID-deficient 
CH12F3 cells, which we used as our CSR-abrogation positive control, and are much different 
from the negative control background, which uses an empty vector backbone (Figure 3.17). 
III.2.3. SETX-deficient CH12 Cells Accumulate RNA:DNA Hybrids 
 Our results suggested that SETX indeed may play a role in the immunoglobulin R-loop 
reaction. Upon elimination of possible other explanations (such as poor cellular proliferation, 
lack of switch sequence transcription, or lack of mutator gene AICDA transcription), we 
entertained the hypothesis that the putative RNA/DNA helicase SETX is mechanistically 
implicated in the Ig R-loop reaction by helping unwind the RNA:DNA hybrids that arise when R 
loops are formed during CSR. In SETX-deficient backgrounds, the RNA moiety of the still-
wound RNA:DNA heteroduplex may not be amenable to degradation or removal by the RNA 
exosome complex, leading to an accumulation of these RNA:DNA hybrids, and, as a 
consequence, to the non-resolution of R loops. We therefore attempted to find evidence of these 
accumulating heteroduplexes. 
 First, we made use of a mouse monoclonal antibody (“S9.6”) that recognizes RNA:DNA 
hybrids (Boguslawski et al., 1986, Bhatia et al., 2014). We stimulated SETX-proficient and 
SETX-deficient CH12F3 cells for 48 hrs with LPS, IL-4, and TGF-β, then harvested, washed, 
fixed, and prepared them for IF. We observed that in the SETX-deficient CH12F3 background, 
there was an increase in the proportion of prepared cells with 2 foci or more, while the 
proportion of prepared cells with no foci or 1 focus decreased compared to the SETX-sufficient 
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background (Figure 3.18). Additionally, although these fixed cells with no foci or 1 focus 
detected accounted for ~ 82% of all the fixed cells in the SETX-sufficient background, but 
comprised less than 50% in the SETX-deficient background (Figure 3.18). 
 We also attempted to corroborate the accumulation of RNA:DNA heteroduplexes in 
SETX-deficient CH12F3 cells using a recombined protein that recognizes RNA:DNA hybrids 
and contains a GFP reporter (“HB-GFP”). This recombined protein was engineered from the 
hybrid-binding domain of RNaseH1 (“HB”) fused to a GFP cassette (Bhatia et al., 2014). The 
HB-GFP construct was introduced into CH12F3 cells by electroporation; the cells are allowed to 
recover overnight, and are then stimulated for CSR. After 1.5 days, GFP-positive cells are sorted, 
permeabilized with Triton X-100, allowing the HB-GFP recombined protein to leak out of the 













DAPI S9.6 (GFP) Merge
Figure 3.18. S9.6 immunofluorescence assay. A. Images of CH12F3 cells containing control 
vector or SETX knockdown vector, stimulated for isotype switching, and assayed by 
immunofluorescence with the anti-RNA:DNA hybrid antibody S9.6. B. A plot of the two 
backgrounds shows an increase in the proportions of prepared cells that have 2, or more than 2, 
S9.6 foci as measured by ImageJ in our assay.
A
B
GFP retention assay would have allowed us to assess RNA:DNA hybrid accumulation using a 
different method; however, we weren’t satisfied with the quality of the assay in CH12F3 cells, 
and could not confidently rely on observations obtained from it. 
III.2.4. SETX-Knockdown CH12F3 Cells Exhibit an Altered Mutational  Profile 
 Beyond the prospects of a mechanistic implication of SETX in the immunoglobulin R-
loop reaction, we wondered what the consequences of such an implication may be. Based on our 
hypothesis, the accumulation of RNA:DNA heteroduplexes would impair proper diversifying 
enzyme AID access to the transcribed DNA strand, and therefore result in a different mutational 
profile at switch sequences. We decided to probe this prediction. We sequenced the 5’-most 
region of switch sequence µ in SETX-sufficient and -deficient CH12F3 cells stimulated to 
undergo isotype switching to IgA by exposure to IL-4, LPS, and TGF-β. We observe that the 
proportion of mutations that occur at GC residues is higher in SETX-deficient CH12F3 cells than 
in control CH12F3 cells; in parallel, the proportion of mutations that occur at AT residues is 
lower in SETX-deficient CH12F3 cells than in SETX-sufficient CH12 cells (Figure 3.19A). We 
wanted to know whether the proportional mutational increase at GC residues occurred at the 
expense of mutations at AT residues. Tellingly, our analysis shows that the mutation rate at GC 
residues in SETX-deficient CH12F3 cells is higher than in SETX-sufficient CH12F3 cells 
(Figure 3.19B). Our analysis also shows that the mutation rate at AT residues is higher in SETX-
deficient CH12F3 cells than in SETX-sufficient CH12F3 cells (Figure 3.19B). However, the 
mutation rate increase from SETX-sufficient to SETX-deficient is more pronounced for GC 
residues compared to AT residues (Figure 3.19B). 
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Figure 3.19. Mutation profile of stimulated SETX-deficient CH12F3 cells. A. Distribution of 
mutations in control and SETX-deficient backgrounds. In the SETX-deficient background, 
compared to the control background, a decrease in the proportion of mutations at AT residues and 
an increase in the proportion of mutations at GC residues are noticeable. B. Further analysis of the 
mutations in the SETX-deficient background shows that overall mutations at AT and GC both 
increase, but that this increase is more pronounced at GC residues, accounting for the opposite 
trends in A. C. Mutation Rate at C residues increases on the non-transcribed strand, and decreases 




 We further probed the alteration of the mutational profile in SETX-deficient CH12F3 
cells. We compared the mutation rate at deoxycytidine residues on the non-transcribed strand to 
the transcribed strand deoxycytidine mutation rate. One would predict that dC residues are 
getting mutated at higher rates on the non-transcribed strand than on the transcribed strand upon 
impairment of SETX activity. Indeed, we notice that compared to the control background, there 
is a marked increase in the mutation rate at dC residues found on the non-transcribed strand in 
SETX-deficient CH12F3 cells (Figure 3.19C). In parallel, there is a decrease in the mutation rate 
at dC residues found on the transcribed strand of SETX-sufficient CH12F3 cells (Figure 3.19C). 
III.2.5. SETX-Mutant Mice Allow for Limited In Vivo Studies 
 Our findings in CH12F3 cells seemed compelling, and we subsequently made an effort to 
expand our investigation to an in vivo model of SETX activity. We obtained four mice (two 
males and two females) heterozygous for SETX, where one allele was wild-type and the other 
reengineered so its open reading frame (ORF) exon 4 (the second of 23 coding exons, the first 
two ORF exons being noncoding) is constitutively and ubiquitously deleted (Becherel et al., 
2013). The mice were mated (Figure 3.20), and splenic B lymphocytes from 6-8 week-old 
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Figure 3.20. SETX mutant mouse. 
Genotyping PCR of 6 animals 
s h o w s t h e d i f f e r e n t S E T X 
backgrounds. Het: heterozygous, 
WT: wild-type, Hom: homozygous.
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Figure 3.21. SETX mutant primary B cell isotype switching and proliferation. A. Staining 
controls are displayed on the top row, while experimental FACS plots are shown on the bottom 
row. B. Several assays suggest a small, statistically significant defect in CSR in SETX mutant 
primary B cells compared to their wild-type counterparts (unpaired student t test, p = 0.0029). 




the usual LPS and IL-4 cocktail to stimulate CSR to IgG1. We then assayed the cells for CSR 
(Figure 3.21A). A number of iterations of the assay later, we observed a small though persistent 
decrease in isotype switching ability in SETX-mutant mice (Figure 3.21B). It seemed like B 
lymphocytes from mutant SETX backgrounds only had a modest statistically significant relative 
decrease in their ability to undergo isotype switching (Figure 3.21B). As with the CH12F3 cell 
line, mutant SETX B cells appeared to proliferate with no ostensible defect (Figure 3.21C). 
 Finally, we also set out to find out if splenic B lymphocytes from mutant SETX mice 
exhibited structural chromosomal instability akin to what we observed with the RNA exosome-
















Figure 3.22. SETX Mutant primary B cell T-FISH. A. 
Examples of telomere loss and dicentric chromosomes 
observed in the T-FISH performed on SETX-mutant cells. 
B. Repeat experiments suggest that the increase in 
instability observed  in the mutant background relative to 
the wild-type is not statistically satisfactory (unpaired 
student t test, p= 0.0992).
A
B
conjectured to be the case in the absence of properly active SETX, would be conducive to an 
increase of genomic instability by making R loops more perennial. We therefore performed a T-
FISH assay on splenic B lymphocytes isolated from SETX mutant and wild-type mice, activated 
them for isotype switching for 72 hours, metaphase-arrested them by colcemid exposure, and 
washed, fixed, and prepared them for telomeric probe hybridization. Although there is some level 
of increase in genomic instability as measured by T-FISH in the SETX-mutant B lymphocytes 
compared to wild-type SETX B lymphocytes, the increase does so far not appear to be 
statistically significant, mirroring our earlier observations that the defects in these mutant mice in 
isotype switching are not very conspicuous (Figure 3.22).  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Chapter IV: Discussion 
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IV.1. Relevance of Work 
 As aspects of the adaptive immune system still seem to be under strong selective 
pressure, critical features of this system have come under scrutiny, particularly as it appears that 
immunoproliferative disorders may be the evolutionary cost for the emergence of an adaptive 
immune system as malleable as ours is. This trade-off is by and large advantageous for us. 
Nonetheless, each time disease strikes, it can be a tragedy; furthermore, our insights into health 
and disease have so far not proved sufficient to staunch overall cancer prevalence or incidence 
rates. Non-Hodgkin Lymphoma rates in particular are of interest to us, as many 
immunoproliferative disorders of mature B-cell origin fall into this category. As is readily 
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Figure 4.1. Incidence rates of non-Hodgkin lymphoma. Most cancers of B cell origin fall into 
the non-hodgkin lymphoma category, which has been trending upwards in the past four decades 
in both males and females. Raw data were obtained from the Surveillance, Epidemiology, and 
End Results (SEER) program of the National Cancer Institute.
appreciable from Figure 4.1, incidence rates of these cancers remain elevated. Similarly, the 
constant threat of infectious diseases, including those caused by multi-drug resistant microbes 
and emergent zoonoses with the possibility of wide and rapid spread, compels us to learn more 
about the adaptive immune system in the hopes of engineering new or more effective ways to 
combat disease.    
 The B-cell arm of the immune system is central to a successful adaptive immune 
response. In particular, its ability to generate and produce high affinity immunoglobulin proteins 
with varied biological functions is a defining characteristic. Much has been learned in the 50 
years since the B cell lineage was identified, including how the first round of lymphocyte 
immunoglobulin diversification occurs, that another round of diversification also occurs 
specifically in B lymphocytes, and that this second round of diversification is instigated by the 
APOBEC deaminase family member AID (Cooper et al., 1965, Kincade et al., 1970, Weigert et 
al., 1970, Honjo and Kataoka, 1978, Tonegawa, 1987, Muramatsu et al., 1999). Recently, efforts 
have been invested in untangling the complex machinery by which the immunoglobulin mutator 
AID is successfully targeted to its physiological substrates while largely sparing other locations, 
and understanding how it sometimes is mis-targeted to regions where its activity might portend 
mutations with dire consequences. Several co-factors of AID activity have been identified, 
including the RNA exosome complex (Basu et al., 2011, Pefanis et al., 2014). 
 Our work has contributed mechanistic insight into the current understanding by providing 
evidence that the immunological R-loop reaction is the molecular key that opens the door to the 
possibility of physiological deamination by AID, and that the regulation of this window of 
carefully orchestrated, physiological instability is mediated by the resolution of transcription-
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initiated R loops. The regulation of this molecular window of instability will ensure that the 
deamination activity of AID happens and is restricted both in time (when AID activity takes 
place) and in space (where AID activity takes place). Transcription allows for the transient 
availability of a looped-out, non-transcribed strand that is rendered more lasting in part by the G-
richness of this strand through the formation of an R loop. The access of the single-stranded 
deaminase AID to its transcribed strand substrate is then facilitated by transcription termination 
during abortive transcription of Ig target loci, notably because these target regions are more 
prone to RNA polymerase stalling and pausing, an occurrence facilitated by the activity of 
stalling/pausing cofactors and that precedes the backtracking and/or release of RNA polymerase 
II, freeing the 3’end of the synthesized RNA that can now be removed or degraded by RNA 
exosome complex, aided in this respect by the unwinding activity of putative helicase SETX; this 
not only unveils the transcribed DNA strand to AID activity, but it also allows the DNA duplex to 
reconstitute, which will close the R loop, and prevent further AID deaminating activity at this 
locus. 
 We explored this hypothesis in various ways. We investigated how altering the activity of 
RNA exosome might impact the structural integrity of the genome. We considered whether or 
how the post-translational modification experienced by RNA polymerase II is involved in the 
maintenance of genomic stability. Finally, we inquired about how SETX may be active during 
the immunoglobulin R-loop reaction.  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IV.2. RNA Exosome and Related Instability 
 We used a conditional deletion model for the abrogation of RNA exosome activity in 
mouse cells. We knew that RNA exosome activity is essential for robust processes of genomic 
remodeling in the immunoglobulin locus (Basu et al., 2011, Pefanis et al., 2014). We suspected 
that the RNA exosome was centrally involved in the regulation of processes like CSR, and more 
specifically, that it is involved in the resolution of R loops found at Ig switch sequences. Given 
the relevance of these structures to the maintenance of genomic integrity, we hypothesized that 
RNA exosome activity during the Ig R-loop reaction helps prevent chromosomal instability. We 
observed that when we prevent RNA exosome complex assembly, and therefore abrogate its 
function, activated B lymphocytes experience a number of catastrophic events, as evidenced 
through our T-FISH assay, and that they are more sensitive to additional mutagenic stress, as 
evidenced by our ionizing radiation immunofluorescence assay.    
 The catastrophic events we witnessed included breaks and fragments (telomere loss, 
acentric chromosomal fragments), as well as rearrangements (dicentric chromosomes, 
homologous end-to-end fusions, radials). One explanation for the loss of telomeres or the 
presence of acentric fragments is cartooned in Figure 4.2, which shows the process by which 
these structures may be encountered in metaphase, and reflects the coinciding first appearance of 
breaks with AID activity in the cell cycle G1 phase before replication.  
 The rearrangement phenotypes can appear when breaks and fragments are repaired 
intrachromosomally through end-to-end homologous fusion or with a different chromosome to 
form a dicentric (Figure 4.3) (rearranged chromosomes are only perceptible to a certain extent 
with our T-FISH assay; some balanced translocations or short intrachromosomal deletions, for 
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instance, would not be detected). These observations were reminiscent of Breakage-Fusion-
Bridge cycles seen in some cancers, when chromosome breakage is repaired by a fusion event 
(between two sister chromatids or between two chromosomes), which is followed by the 
formation of a “bridge” during mitosis that gets broken again as the spindle pulls on each 
centromere to re-create broken ends available for another cycle (Sorzano et al., 2013, Feijoo et 
al., 2014). As for the radials, they are thought of as chromatid-type break (affecting only one 
chromatid, in contrast to both chromatids being affected in the chromosome-type breaks) that 
arise at sites of stalled replication forks and are repaired by the presumably non-physiological 
insertion of another chromosome (Savage, 1976, Scully et al., 2000, Satoh et al., 2002). Our 
results would then hint at the possibility that chromosome-type breaks (involving both 
chromatids, typically G1, pre-replicative in origin) occur more frequently than chromatid-type 


































































Adapted from Franco et al., 2008
Figure 4.2. Generation of 
Breaks/Fragments Phenotype. 
After a break in G1 phase that 
fails to be properly repaired, 
r ep l i ca t ion in S phase 
proceeds, and the resulting 
telomere loss or acentric 
fragment is detected in the 
following metaphase.
stalling occurs, and which are more susceptible to replication fork stalling and collapse, are often 
associated with these chromatid-type breaks that occur later in replication. 
 These observations also highlighted the possibility that instability events might be 
occurring at different times in the cell cycle (like the less frequent radials) or at additional sites 
sensitive to RNA exosome activity abrogation. Indeed, R-loop formation has been reported at 
several other locations, including the non-coding telomeric repeat–containing RNA (TERRA) 
transcripts (Cusanelli and Chartrand, 2015). The description of early replicating fragile sites 
(ERFSs), which similarly to CFSs, are sites prone to breakage, but contrary to them, occur early 
during replication, poses the question of whether they, too, could be loci where R loops are 








Figure 4.3. Generation of 
Fusion Phenotypes. Dicentric 
chromosomes and homologous 
end-to-end chromosomes may 
arise when the cell repairs a 
break in a chromosome by 
adjoining two sister chromatids 
or a different chromosome in a 
translocation event.
particularly consequential (Barlow et al., 2013). Comparing ERFS hotspots and AID targets, we 
could see that at least two loci belonged in both categories, including one, IRF4, affected in B 
cell cancer (Figure 4.4). Finally, the recent identification by our group of long non-coding RNAs 
and R-loop forming divergently transcribed transcription start-site and enhancer RNAs as 
substrates of the RNA exosome complex is auspicious, particularly given that some of these 
newly identified RNA exosome substrates, such as BIRC3 and NCOA3 enhancers, are involved 
in translocation events with the IGH locus described in translocation capture studies (Klein et al., 
2011, Pefanis et al., 2014, Pefanis et al., 2015). This is strong indication that subsequent studies 
should investigate the identity of the loci involved in instability events with greater resolution 
than our SKY assay or than G-banding studies. One possible route to follow would be the use of 
2-color IGH BAC-FISH, which would produce further evidence of IGH locus involvement, 
possibly in a translocation event (Figure 4.5). Another possible, more high-throughput avenue 
would include translocation capture assays of activated RNA exosome-deficient B cells. These 
would give us insights into the presence of translocation events, as well as the identity of such 
events. 
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Figure 4.5. 2-Color IGH BAC-FISH. Bacterial artifical chromosome-fluorescence in situ 
hybridization using 2 BAC probes (digoxigenin-labeled upstream of VDJ and more telomeric, 
and biotin-labeled downstream of Cα and more centromeric) flanking the IGH locus on 
metaphase-arrested B lymphocytes. The probes are then detected using FITC-tagged anti-
digoxigenin fragment or Cy5-tagged streptavidin.
VDJ Eµ Cµ C∂ Cγ3 Cγ1 Cγ2b Cγ2a Cε CαSµ Sγ1 3’RR
             BAC 207 
(digoxigenin-labeled;FITC-anti-dig fragment-detected)







IV.3. AID Dependence? 
 Our experiments in B cells were accompanied by similar experiments in an ES cell 
background. We wanted to explore the same questions we asked for stimulated B cells in a 
background deprived of class-switch recombination ability.  
 We used the same ROSA26Cre-ERT2/+; EXOSC3COIN/COIN animal background as for our B 
cell RNA exosome studies. Initially, we had sought to induce RNA exosome activity-deficient B 
cell proliferation with RP105, which reportedly allows B cells to proliferate without eliciting 
AID expression (Miyake et al., 1995, Callén et al., 2007). But we turned to ES cells, when these 
attempts were not satisfactory; moreover, one potent benefit of using B cells is that they might 
provide a better control system because they negate possible inter-animal differences since all the 
ES cells we study are from the same embryo, and what is compared is the instability profiles 
before and after RNA exosome activity abrogation. T-FISH assays on RNA exosome-deficient 
metaphase-arrested ES cells in ES cells revealed the accumulation of structural chromosomal 
catastrophic events of the same nature as observed in our B-cell T-FISH assay. In an effort to 
compare the two different backgrounds, we normalized the levels of instability to their respective 
cell-specific baseline instability levels (that is, instability level observed without abrogating RNA 
exosome activity) to create an instability index, and noticed that the latter was more elevated in 
B cells (4.33) than in ES cells (2.67). These results would therefore suggest that AID might 
account for the difference between the two instability indices. In this scenario, the instability 
observed in the non-switching RNA exosome-deficient ES cells may be accounted for by the 
presence of stress related to proliferation, particularly if transcription-associated and/or 
replication-associated events at fragile DNA segments prone to forming non-B (including G4) 
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DNA, TERRA loci, fragile sites (early and/or common), divergently-transcribed transcription 
start sites, and loci encoding long non-coding RNA or enhancer RNA are occurring (Reddy and 
Vasquez, 2005, Kim and Jinks-Robertson, 2012, Pefanis et al., 2014, Cusanelli and Chartrand, 
2015, Pefanis et al., 2015). 
 In a different experimental setup, we performed T-FISH assays on activated, then 
metaphase-arrested, NEDD4-/- B lymphocytes (from fetal liver chimeras) (Sun et al., 2013a). Our 
results suggest that there is no increase in genomic instability in the absence of NEDD4 in 
activated B cells. This is interesting, because NEDD4 is thought to promote the activity of AID 
in B cells, in part by facilitating its interaction with its SPT5 and RNA exosome cofactors. At the 
same time, although NEDD4 is thought to monoubiquitinate RNA polymerase II (an event that 
precedes RNA polymerase II polyubiquitination and its degradation), neither RNA polymerase II 
levels nor immunoglobulin transcript production at switch sequences are decreased in the 
absence of NEDD4 (Sun et al., 2013a). However, RNA exosome core subunit RRP40 is much 
less recruited to switch sequence IgSµ in NEDD4 knockdown CH12F3 cells stimulated for 
isotype switching (Sun et al., 2013a). The observation that no increase in genomic instability was 
detected in our T-FISH assay of NEDD4-/- primary B cells, even though NEDD4 knockdowns in 
CH12F3 cells suggest that AID activity is deficient, RNA exosome recruitment is deficient, and 
transcription is unaffected, indicates that the genomic instability we observed in B cells in the 
absence of proper RNA exosome function is at least partly AID-dependent. Mating AID 
knockout mice to our conditional deletion system background would provide us with a useful 
experimental tool, particularly in light of the hypothesis that AID may mediate epigenetic 
regulation in pluripotent tissues (Morgan et al., 2004).  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IV.4. A Role for Senataxin 
 As we attempted to understand the workings of the Ig R-loop reaction by investigating 
the role played by the RNA exosome complex, we decided to study the possible involvement of 
the putative RNA/DNA 5′ → 3′ helicase senataxin (SETX) and hypothesized it helps unwind 
RNA:DNA hybrid duplexes to facilitate the RNA exosome-mediated removal/degradation of R-
loop RNA:DNA heteroduplex RNA moieties (Figure 4.6).  
 We saw that in human Burkitt’s lymphoma cell line RA.1 (Ramos cells) SETX 
immunoprecipitates with RNA exosome core subunit RRP45 and with CSR initiator mutagen 
AID, placing it in the middle of the Ig R-loop reaction. We established a SETX-knockdown 
system in the murine CH12F3 cell line, where class-switch recombination could be assayed, and 
found that when SETX expression is decreased, CSR becomes impaired. We also found evidence 



















Figure 4.6. SETX Hypothesis. Physiologic SETX levels would permit the unwinding of 
RNA:DNA hybrids and favor their removal by RNA exosome to resolve R loops and carry out 
physiological AID-mediated mutagenesis. In the absence of physiological SETX levels, 
RNA:DNA hybrids would accumulate, not get resolved, and mediate pathophysiological 
breaks, some of which at least are mediated by AID.
system were limited because no satisfactory commercial antibody against mouse SETX is 
available. Nevertheless, and importantly, we studied a 5’-most switch sequence Sµ segment for 
mutational analysis, and observed that in senataxin-deficient backgrounds, the mutational profile 
at these AID target loci changes, with mutations accruing on the non-transcribed strand relative 
to the transcribed strand, as would be predicted from our hypothesis (Figure 4.6). 
 We used a mouse model where SETX exon 4 has been deleted, abrogating the function of 
the protein constitutively (Becherel et al., 2013). Our findings using this model were decidedly 
more tempered than in the knockdown CH12F3 background. We saw a small, though consistent 
decrease in the percentage of IgG1+ activated B cells from mutant mice compared to wild-type 
activated B lymphocytes. Moreover, our T-FISH assay on these cells revealed a modest increase 
in genomic instability. These observations suggest the possible existence of redundant pathways 
in primary B cells that are somehow not present or less functional in the CH12F3 cells. Several 
candidates could fall into this category. MTR4 (mRNA transport 4) is a member of the RNA 
helicase superfamily 2 that forms the TRAMP complex (Trf4/Trf5 poly(A) polymerases, Air1/
Air2 Zn-knuckle RNA-binding proteins, and Mtr4 RNA helicase) known to interact with the 
RNA exosome complex (Houseley et al., 2006, Houseley and Tollervey, 2009, Schuch et al., 
2014). Another potential candidate is aquarius (AQR), which, unlike MTR4, but like SETX, is a 
putative RNA/DNA helicase member of RNA helicase superfamily 1; AQR activity, like that of 
SETX, has also been associated to R-loop resolution (Sollier et al., 2014, De et al., 2015). 
Studies of the Ig R-loop reaction in the absence or impairment of one or a combination of all 
these helicases would surely be insightful. Given that some of them are reportedly essential, like 
SETX, a possible way to study them might be the generation of mutants in lieu of outright 
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constitutive deletion. This evokes another explanation for our mouse phenotype, which is that it 
may represent a hypomorph of some sort, or a differently spliced gene product, given the absence 
of pronounced neurological phenotype despite the association of SETX with at least ALS4 and 
AOA2 (Becherel et al., 2013). This may be worth exploring given reports of alternative splicing 
and transcription start sites (Fogel et al., 2009). 
 We initiated the CRISPR-directed generation of SETX mutants in CH12F3 cells. 
Preliminary observations in non-fully characterized lines suggest that the ability of these cells to 
undergo isotype switching to IgA might be impaired, and, just as in the knockdown experiments, 
their phenotype is more akin to an AID-mutant control, without discernible growth defects (Data 
not shown). It remains to be seen what the result of these investigations will be once single 
clones are isolated. However, if they are successful, they could give us a deeper understanding of 
the mechanisms behind RNA:DNA unwinding and RNA removal/degradation during the Ig R-
loop reaction. In addition, the generation of mice harboring these mutations could provide a 
system to investigate whether SETX or other helicase activity impairment can precipitate 
genomic instability in stimulated B lymphocytes, which we were not able to test in our CH12F3 
system, given the transformed nature of the cell line.  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IV.5. Concluding Remarks 
 Our work helps demonstrate why disrupting physiological R loop balance may be 
problematic in activated B lymphocytes (Figure 4.7). While suboptimal class-switch 
recombination results from the inadequate generation of R loops, the accumulation of the latter 
without their timely resolution is a source of mutations, double strand breaks, pathophysiological 
translocations, the occurrence of all of which hinders proper CSR. Failure to adequately resolve 
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R Loops






Figure 4.7. R Loop in CSR and Immunocompetency. R loop formation and resolution 
constitute the mechanism by which a molecular window of instability is opened and closed 
to allow for carefully orchestrated, time- and space-restricted, physiological mutagenesis by 
AID. Altering physiological R loop balance is then problematic, and may translate into 
suboptimal CSR, mutations, double-stranded breaks, pathophysiologic translocations, the 
combined occurrence of all of which hinders proper CSR. Failure to adequately resolve R 
loops, as in exosome or senataxin-deficient backgrounds, impairs physiological NHEJ-
mediated CSR, as the mutations and breaks that are produced are addressed in ways that are 
incompatible with CSR.
R loops, as in RNA exosome- or senataxin-deficient backgrounds, impairs physiological NHEJ-
mediated CSR, as the mutations and breaks that are produced are addressed in ways that are 
incompatible with CSR. These catastrophic events may be even compounded by AID-
independent breaks in B cells, because of the presence of sensitive sites.  
 RNA Exosome and B-cell genomic instability. Using a conditional inversion/deletion 
system that abrogates the synthesis of core RNA exosome subunit RRP40 and prevents the 
proper assembly of the RNA exosome complex, we observed that B cells stimulated to undergo 
isotype switching are deficient in the physiological recombination reaction and instead 
accumulate structural chromosomal instability events. We hypothesized that some of these events 
are the result of inordinate AID mutational activity at unresolved RNA exosome-related R loops, 
causing double stranded breaks that fail to be repaired physiologically. One prediction from our 
R-loop accumulation hypothesis is that these cells are more sensitive and prone to double 
stranded breaks in conditions of increased mutagenic load. We stressed the cells by exposing 
them to varying levels of ionizing radiation, and observed that, indeed, RNA exosome-deficient 
B cells are more likely to accumulate DSBs than RNA exosome-sufficient cells, particularly 
when confronted with increasing mutagenic stress. Finally, we were also able to identify by 
spectral karyotyping technology structural changes involving the IGH-bearing chromosome 12 
as well as chromosomes 1 and 17, which in mouse contain proto-oncogenes.  
 Senataxin and B-cell genomic instability. In parallel, we made an effort to identify 
possible RNA exosome co-factors that similarly may be implicated in maintaining the integrity 
of the B-cell genome. We used both a knockdown, in-vitro approach, as well as a mouse model. 
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More recently, we also initiated a knock-out in-vitro system. We report that SETX associates 
with RNA exosome complex subunit RRP45 as well as AID in a B-lymphocyte cell line. 
Importantly, we see that SETX-deficient cells exhibit impaired CSR. Moreover, cells lacking 
physiological SETX activity accumulate RNA:DNA heteroduplexes. Finally, we observe that 
SETX deficiency leads to an increase in mutations on the template strand, particularly at 
deoxycitidine residues. These results help us better understand the mechanistic underpinnings of 
AID targeting to its substrates during isotype switching.  
 AID dependence. We wanted to test the extent to which our observations were AID-
dependent. We used ES cells from our conditional ROSA26Cre-ERT2/+; EXOSC3COIN/COIN mouse 
model which proliferate extensively but do not undergo isotype switching and performed T-FISH 
assays that revealed an increase in instability in the absence of physiological RNA exosome 
activity. Tellingly, this ES-cell instability does not appear to be as elevated as in B cells. The 
dysregulation of proper RNA processing mechanisms in B cells may thus lead to oncogenic 
translocations as a result of the concerted effects of both AID-related mutagenesis and 
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